<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84382</article-id><article-id pub-id-type="doi">10.7554/eLife.84382</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-75562"><name><surname>Kim</surname><given-names>Sang Hwa</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9245-4514</contrib-id><email>shkim9@wisc.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-298701"><name><surname>Nichols</surname><given-names>Kye D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-228412"><name><surname>Anderson</surname><given-names>Eric N</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-298702"><name><surname>Liu</surname><given-names>Yining</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2632-7119</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-298703"><name><surname>Ramesh</surname><given-names>Nandini</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-298704"><name><surname>Jia</surname><given-names>Weiyan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-298705"><name><surname>Kuerbis</surname><given-names>Connor J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-56986"><name><surname>Scalf</surname><given-names>Mark</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-56989"><name><surname>Smith</surname><given-names>Lloyd M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6652-8639</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-131290"><name><surname>Pandey</surname><given-names>Udai Bhan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6267-0179</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-75563"><name><surname>Tibbetts</surname><given-names>Randal S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2245-2297</contrib-id><email>rstibbetts@wisc.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01y2jtd41</institution-id><institution>Department of Human Oncology, University of Wisconsin School of Medicine and Public Health</institution></institution-wrap><addr-line><named-content content-type="city">Madison</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04ehecz88</institution-id><institution>Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01y2jtd41</institution-id><institution>Department of Chemistry, University of Wisconsin-Madison</institution></institution-wrap><addr-line><named-content content-type="city">Madison</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chin</surname><given-names>Jeannie</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Baylor College of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ron</surname><given-names>David</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>11</day><month>04</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e84382</elocation-id><history><date date-type="received" iso-8601-date="2022-10-22"><day>22</day><month>10</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-04-06"><day>06</day><month>04</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-11-01"><day>01</day><month>11</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.10.31.514355"/></event></pub-history><permissions><copyright-statement>© 2023, Kim et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Kim et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84382-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-84382-figures-v2.pdf"/><abstract><p>Mutations in the ubiquitin (Ub) chaperone <italic>Ubiquilin 2 (UBQLN2</italic>) cause X-linked forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) through unknown mechanisms. Here, we show that aggregation-prone, ALS-associated mutants of UBQLN2 (UBQLN2<sup>ALS</sup>) trigger heat stress-dependent neurodegeneration in <italic>Drosophila</italic>. A genetic modifier screen implicated endolysosomal and axon guidance genes, including the netrin receptor, Unc-5, as key modulators of UBQLN2 toxicity. Reduced gene dosage of <italic>Unc-5</italic> or its coreceptor <italic>Dcc/frazzled</italic> diminished neurodegenerative phenotypes, including motor dysfunction, neuromuscular junction defects, and shortened lifespan, in flies expressing UBQLN2<sup>ALS</sup> alleles. Induced pluripotent stem cells (iPSCs) harboring UBQLN2<sup>ALS</sup> knockin mutations exhibited lysosomal defects while inducible motor neurons (iMNs) expressing UBQLN2<sup>ALS</sup> alleles exhibited cytosolic UBQLN2 inclusions, reduced neurite complexity, and growth cone defects that were partially reversed by silencing of <italic>UNC5B</italic> and <italic>DCC</italic>. The combined findings suggest that altered growth cone dynamics are a conserved pathomechanism in UBQLN2-associated ALS/FTD.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>amyotrophic lateral sclerosis</kwd><kwd>UBQLN2</kwd><kwd>axon guidance</kwd><kwd>induced motor neuron</kwd><kwd>genetic screen</kwd><kwd>protein aggregation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>R21 AG065896-01A1</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Sang Hwa</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1RF1AG069483-01A1</award-id><principal-award-recipient><name><surname>Tibbetts</surname><given-names>Randal S</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>1R21 NS101661-01-A1</award-id><principal-award-recipient><name><surname>Tibbetts</surname><given-names>Randal S</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000971</institution-id><institution>ALS Association</institution></institution-wrap></funding-source><award-id>Proteostatic regulation by Ubiquilins in ALS</award-id><principal-award-recipient><name><surname>Tibbetts</surname><given-names>Randal S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Axon guidance genes are conserved regulators of neurodegeneration in <italic>Drosophila melanogaster</italic> and human inducible motor neuron models of UBQLN2-associated amyotrophic lateral sclerosis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><sec id="s1-1"><title>Ubiquilins and proteostasis</title><p>Defective protein folding and proteostatic stress are common pathogenic mechanisms linking genetically and anatomically diverse neurodegenerative diseases (<xref ref-type="bibr" rid="bib53">Ling et al., 2013</xref>). The steady state levels—and ultimately neurotoxicity—of aggregation-prone proteins are determined through a balance of protein production and protein clearance (<xref ref-type="bibr" rid="bib69">Prahlad and Morimoto, 2009</xref>). The convergence of aging-dependent declines in protein degradation and nuclear import with environmental stresses may push this equation toward irreversible protein aggregation that sets the stage for neurodegenerative processes (<xref ref-type="bibr" rid="bib63">Morimoto, 2008</xref>). Thus, enhancing protein degradation capacity—or reducing the aggregation potential of aggregation-prone proteins—represents a promising therapeutic avenue for amyotrophic lateral sclerosis (ALS) and other neurodegenerative proteinopathies.</p><p>The highly conserved ubiquilin (UBQLN) gene family fulfills diverse roles in protein folding, shuttling, and degradation (<xref ref-type="bibr" rid="bib97">Zheng et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Rothenberg and Monteiro, 2010</xref>). All eukaryotic UBQLNs feature an amino-terminal ubiquitin-like (UBL) domain and a carboxyl-terminal ubiquitin-associated (UBA) domain separated by a low complexity, methionine-rich central region harboring variable numbers of STI1-like repeats first identified in the yeast stress-inducible 1 (Sti1) protein and later described in several distinct classes of protein chaperones (<xref ref-type="bibr" rid="bib25">Fry et al., 2021</xref>; <xref ref-type="bibr" rid="bib99">Zientara-Rytter and Subramani, 2019</xref>; <xref ref-type="bibr" rid="bib30">Howe et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Schmid et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Li et al., 2013</xref>). Mammals encode four ubiquilin proteins of which three (UBQLN1, UBQLN2, and UBQLN4) are widely expressed. UBQLN1 and UBQLN2 share &gt;70% amino acid identity and are presumed to function in semi-redundant fashion, whereas UBQLN4 is a more distantly related paralog.</p><p>Although specific functions of individual ubiquilins in mammals are largely unknown, a generic model for UBQLN function holds that the UBA domain engages ubiquitylated substrate while the UBL domain engages the proteasome, leading to substrate degradation (<xref ref-type="bibr" rid="bib33">Itakura et al., 2016</xref>). STI1-like repeats form a hydrophobic groove that is thought to engage hydrophobic regions of client proteins (<xref ref-type="bibr" rid="bib25">Fry et al., 2021</xref>). It has been reported that UBQLN deficiency (Df) leads to defects in autophagy and ER-associated protein degradation (<xref ref-type="bibr" rid="bib71">Rothenberg et al., 2010</xref>; <xref ref-type="bibr" rid="bib52">Lim et al., 2009</xref>; <xref ref-type="bibr" rid="bib65">N’Diaye et al., 2009</xref>; <xref ref-type="bibr" rid="bib46">Lee et al., 2013</xref>). The central methionine-rich domain has been shown to bind transmembrane domains of mitochondrial proteins, which appears central to their UBQLN-dependent triage and degradation (<xref ref-type="bibr" rid="bib33">Itakura et al., 2016</xref>).</p></sec><sec id="s1-2"><title>UBQLN2 mutations in ALS/dementia</title><p>Interest in ubiquilin function was greatly stimulated by the discovery that dominant mutations in UBQLN2 cause X-linked ALS/frontotemporal dementia (FTD) (<xref ref-type="bibr" rid="bib18">Deng et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Gellera et al., 2013</xref>). Most ALS-associated mutations in UBQLN2 are clustered within 42-amino acid proline-rich repeat (PRR) that is unique to UBQLN2 (<xref ref-type="bibr" rid="bib18">Deng et al., 2011</xref>) however, disease-linked mutations outside this region have also been described (<xref ref-type="bibr" rid="bib80">Synofzik et al., 2012</xref>; <xref ref-type="bibr" rid="bib16">Daoud et al., 2012</xref>). In addition, UBQLN2-mutant patients exhibit a range of phenotypes that includes FTD, ALS, and spastic paraplegia (<xref ref-type="bibr" rid="bib27">Gkazi et al., 2019</xref>). Interestingly, ubiquilin-positive aggregates are a near universal occurrence in TDP-43-positive ALS, as well as ALS linked to <italic>C9ORF72</italic> expansions (C9-ALS) (<xref ref-type="bibr" rid="bib9">Brettschneider et al., 2012</xref>). These correlative findings suggest that ubiquilin pathology may contribute to the molecular pathogenesis of ALS even in the absence of <italic>UBQLN2</italic> gene mutations.</p><p>Transgenic or virus-directed expression of UBQLN2<sup>ALS</sup> mutants in rodents recapitulates protein UBQLN2 inclusions seen in ALS/FTD patients and elicits variable phenotypic abnormalities ranging to mild gait and memory defects to neuronal loss, paralysis, and early death (<xref ref-type="bibr" rid="bib28">Gorrie et al., 2014</xref>; <xref ref-type="bibr" rid="bib93">Wu et al., 2015</xref>; <xref ref-type="bibr" rid="bib32">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Le et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Sharkey et al., 2020</xref>). Coexpression of UBQLN2<sup>P497H</sup> and an ALS-associated TDP-43 allele under control of the neurofilament heavy gene promoter caused severe motor neuron loss and muscle wasting (<xref ref-type="bibr" rid="bib67">Picher-Martel et al., 2019</xref>). Brain-directed expression of wild-type UBQLN2 also caused toxicity phenotypes (<xref ref-type="bibr" rid="bib32">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Le et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Sharkey et al., 2020</xref>), potentially due to disruptions in Ub homeostasis. Finally, like many proteins implicated in ALS/FTD (<xref ref-type="bibr" rid="bib66">Pakravan et al., 2021</xref>), UBQLN2 harbors low complexity regions and undergoes liquid-liquid phase separation (<xref ref-type="bibr" rid="bib74">Sharkey et al., 2018</xref>; <xref ref-type="bibr" rid="bib15">Dao et al., 2018</xref>). While ALS-associated mutations in the PRR may interfere with UBQLN2 liquid demixing, the relevance to disease pathogenesis is presently unclear.</p><p>In previous work, we reported that expression of ALS-associated <italic>UBQLN2</italic> mutants caused mutation-dependent neurotoxicity in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>). Here, we carried out genetic screens for UBQLN2 toxicity modifiers using flies expressing UBQLN2<sup>ALS</sup> alleles with differing aggregation potential. Suppressor genes emerging from this screen were then tested for impacts on the toxicity of endogenous UBQLN2<sup>ALS</sup> mutants in iMNs. Our findings suggest that endolysosomal dysfunction and axon guidance defects are phenotypic drivers of neurodegeneration in UBQLN2-associated ALS/FTD.</p></sec></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>An aggregation-prone UBQLN2<sup>4XALS</sup> allele exhibits heat stress-dependent eye toxicity</title><p>We previously reported that homozygous expression of single-copy human UBQLN2<sup>ALS</sup> alleles caused mild eye toxicity when expressed under control of an eye-specific GMR driver at 22°C (<xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>). Reasoning that UBQLN2-associated phenotypes may be worsened by heat stress (HS), we compared eye morphologies between flies expressing UBQLN2<sup>WT</sup>, a clinical UBQLN2<sup>P497H</sup> allele, and a highly aggregation-prone UBQLN2<sup>4XALS</sup> mutant that harbors four different clinical mutations (P497H, P506T, P509S, and P525S, <xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>). None of the UBQLN2 transgenes caused an overt external eye phenotype when expressed from a hemizygous GMR&gt;UBQLN2 Chr2 locus at 22°C (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). By contrast, GMR&gt;UBQLN2<sup>4XALS</sup> flies—but not GMR&gt;UBQLN2<sup>WT</sup> or GMR&gt;UBQLN2<sup>P497H</sup> flies—exhibited a moderately severe rough eye (RE) phenotype that was characterized by eye depigmentation and loss of ommatidial facets in both male and female flies (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). As expected, UBQLN2<sup>4XALS</sup> was significantly less soluble than UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> at both 22°C and 29°C; however, the relative proportion of insoluble UBQLN2<sup>4XALS</sup> was comparable at both temperatures, suggesting that increased aggregation of UBQLN2<sup>4XALS</sup> cannot wholly account for its enhanced toxicity at 29°C (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>UBQLN2 exerts heat stress (HS)-dependent toxicity.</title><p>(<bold>A</bold>) Schematic of UBQLN2 and amyotrophic lateral sclerosis (ALS)-associated mutations. Approximate locations of ubiquitin-like (UBL); STI1-like (STI); proline-rich repeat (PRR); and ubiquitin-associated (UBA) domains are shown, as are ALS-associated mutations investigated in this study. (<bold>B</bold>) Eye images from flies expressing UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, UBQLN2<sup>P525S</sup>, or UBQLN2<sup>4XALS</sup> under control of the eye-specific GMR driver at 22°C and 29°C. Note depigmentation and destruction of ommatidial facets in UBQLN2<sup>4XALS</sup> flies reared at 29°C.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Ubiquitin (Ub)-binding contributes to eye degeneration and aggregation of UBQLN2<sup>ALS</sup> mutants.</title><p>(<bold>A</bold>) Expression and RIPA solubility of UBQLN2 proteins in head extracts prepared from GMR&gt;UBQLN2 flies of the indicated genotype. Ten flies per genotype. (<bold>B</bold>) Quantification of RIPA solubility of UBQLN2 proteins in head extracts prepared from GMR&gt;UBQLN2 flies of the indicated genotype. Triplicate of 10 flies per genotype. The bars represent mean with <italic>SEM</italic> of triplicate samples. Unpaired t-test was used for statistical analysis. *p≤0.05, ***p≤0.001. (<bold>C</bold>) Relative abundance of <italic>Drosophila</italic> Ubqln (dUbqln) and human UBQLN2 (hUBQLN2) in GMR &gt; UBQLN2 flies. Head extracts from flies of the indicated genotypes were analyzed by mass spectrometry (MS) to determine peptide spectral matches (PSM) for dUbqln and hUBQLN2 at 22°C and 29°C. MS was carried out using 100 flies per genotype. The bars represent mean with <italic>SEM</italic> from triplicate samples. Unpaired t-test was used for statistical analysis.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Uncropped Western blot images corresponding to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>, and PSM corresponding to <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig1-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Gene expression profiles of GMR&gt;UBQLN2<sup>ALS</sup> flies.</title><p>(<bold>A</bold>) Venn diagram of differentially expressed genes (DEGs) (amyotrophic lateral sclerosis [ALS]) from comparisons of GMR&gt;UBQLN2<sup>WT</sup>, GMR&gt;UBQLN2<sup>P497H</sup>, and GMR&gt;UBQLN2<sup>4XALS</sup> to GMR-Gal4 control flies reared at 29°C. (<bold>B</bold>) Principle component analysis of RNA-Seq data from whole heads of GMR, GMR&gt;UBQLN2<sup>WT</sup>, GMR&gt;UBQLN2<sup>P497H</sup>, and GMR&gt;UBQLN2<sup>4XALS</sup> flies reared at 22°C or 29°C. (<bold>C</bold>) Venn diagram of DEGs from comparisons of GMR-Gal4 control, GMR&gt;UBQLN2<sup>P497H</sup>, and GMR&gt;UBQLN2<sup>4XALS</sup> to GMR&gt;UBQLN2<sup>WT</sup>flies reared at 29°C. (<bold>D</bold>) Heat map of genes differentially expressed between GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>4XALS</sup> fly heads at 29°C. (<bold>E</bold>) Volcano plot depicting genes differentially expressed between GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>4XALS</sup> flies at 29°C. Downregulated photoreceptor genes, upregulated innate immunity genes, and upregulated small HSPs are highlighted. (<bold>F</bold>) DEGs common to GMR&gt;UBQLN2<sup>P497H</sup> and GMR&gt;UBQLN2<sup>4XALS</sup> flies in comparison to GMR&gt;UBQLN2<sup>WT</sup> flies at 29°C.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Gene expression data sets corresponding to <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig1-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig1-figsupp2-v2.tif"/></fig></fig-group><p>We also performed quantitative mass spectrometry (MS) to assess relative abundance of UBQLN2<sup>WT</sup>, UBQLN2<sup>4XALS</sup>, and endogenous <italic>Drosophila</italic> Ubqln (dUbqln) in whole-head extracts. The average number of peptide spectral matches for hUBQLN2 was comparable between GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>4XALS</sup> flies reared at 22°C and 29°C (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). hUBQLN2-unique peptides were ~6-fold more abundant than dUbqln peptides in both GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>4XALS</sup> heads, providing a lower limit of hUBQLN2 overexpression (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). As expected, given the heat inducibility of UAS, absolute numbers of hUBQLN2 peptides were higher in GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>4XALS</sup> flies reared at 29°C versus 22°C; however, the difference was not statistically significant across three replicates. Altogether these findings established HS-dependent toxicity of UBQLN2<sup>4XALS</sup> that is not solely due to increased protein expression.</p></sec><sec id="s2-2"><title>Transcriptomic analysis of UBQLN2<sup>ALS</sup> flies</title><p>We next performed RNA-Seq analysis of whole heads from GMR&gt;UBQLN2<sup>WT</sup>, GMR&gt;UBQLN2<sup>P497H</sup>, GMR&gt;UBQLN2<sup>4XALS</sup>. Each of the three GMR&gt;UBQLN2 lines exhibited hundreds of gene expression changes relative to GMR-Gal4 controls, suggesting that UBQLN2 overexpression has a substantial impact on cellular regulation (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Consistent with their more severe eye phenotype, GMR&gt;UBQLN2<sup>4XALS</sup> flies exhibited a distinct RNA-Seq gene expression signature relative to GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>P497H</sup> flies, which clustered together in principle component analysis (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). Using an FDR of &lt;0.05, 629 genes were uniquely changed in GMR&gt;UBQLN2<sup>4XALS</sup> flies versus GMR&gt;UBQLN2<sup>WT</sup>, GMR&gt;UBQLN2<sup>P497H</sup>, and GMR-Gal4 controls at 29°C (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>, <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>). Of these, 402 genes were upregulated and 227 genes were downregulated in GMR&gt;UBQLN2<sup>4XALS</sup> flies (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D, E</xref>, Supplementary Dataset 1 and 2, respectively). Gene ontology (GO) analysis revealed that mRNAs involved in eye development and phototransduction, including inaC, ninaE, and Rh3, were broadly downregulated in GMR&gt;UBQLN2<sup>4XALS</sup> flies, likely reflecting degenerative cell loss (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D, E</xref>, Supplementary Dataset 2). Upregulated GO terms included response to biotic stimulus, which includes <italic>Drosophila</italic> innate immunity genes such as <italic>Dro</italic>, <italic>AttB</italic>, <italic>AttC</italic>, and <italic>Listericin</italic>, and response to UV light, which includes the small heat-shock protein-encoding genes <italic>Hsp23</italic>, <italic>Hsp26</italic>, and <italic>Hsp27</italic> (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D, E</xref>, Supplementary Dataset 1). Upregulation of HSPs may be driven by UBQLN2<sup>4XALS</sup> misfolding. In contrast to the profound differences between GMR&gt;UBQLN2<sup>4XALS</sup> and GMR&gt;UBQLN2<sup>WT</sup> flies, only 64 genes were differentially expressed between GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>P497H</sup> flies, which is consistent with their qualitatively similar eye phenotypes. Finally, 28 differentially expressed genes were common to GMR&gt;UBQLN2<sup>4XALS</sup> and GMR&gt;UBQLN2<sup>P497H</sup> flies relative to GMR&gt;UBQLN2<sup>WT</sup> flies (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>). Overall, these findings reveal that the strong eye phenotype of GMR&gt;UBQLN2<sup>4XALS</sup> is accompanied by robust changes in gene expression.</p></sec><sec id="s2-3"><title>Df screens for UBQLN2<sup>ALS</sup> modifier genes</title><p>The RE phenotype of GMR&gt;UBQLN2<sup>4XALS</sup> flies allowed us to perform genetic modifier screens. To this end, we screened a Bloomington Df library of 194 lines spanning 85% of chromosome 2 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The screen was carried out at 29°C and eye phenotypes were scored on a scale of 1–5, with a score of ‘1’ representing a morphologically normal eye; a score of ‘3’ representing the unmodified UBQLN2<sup>4XALS</sup> eye phenotype; and a score of ‘5’ representing eyes harboring &gt;50% necrotic patches (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Lethal enhancers were also noted. While the mild eye phenotype of GMR&gt;UBQLN2<sup>P497H</sup> flies largely precluded identification of suppressors, the side-by-side screening of this line allowed us to identify shared and/or mutation-specific enhancers. Candidate modifier Dfs were subjected to secondary screens against UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup>.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Identification of UBQLN2 modifier genes.</title><p>(<bold>A</bold>) Schematic of deficiency (Df) screen for UBQLN2 modifiers. (<bold>B</bold>) Representative eye images and scoring rubric for F1 progeny of GMR&gt;UBQLN2<sup>4XALS</sup> flies crossed to Df lines. (<bold>C</bold>) Representative UBQLN2<sup>4XALS</sup> modifier genes. Eye images were taken of F1 progeny from crosses of GMR&gt;UBQLN2<sup>4XALS</sup> to indicated Df lines at 1–3 days post eclosion. Suppressors and enhancers are shown in top and bottom rows, respectively. (<bold>D</bold>) Representative eye images of UBQLN2<sup>P497H</sup> enhancers. Arrows indicate foci of eye degeneration. Eye degeneration scores are displayed below each eye image (<bold>B, C, D</bold>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>List of Dfs that modified GMR&gt;UBQLN2<sup>P497H</sup> and/or GMR&gt;UBQLN2<sup>4XALS</sup> eye phenotypes corresponding to <xref ref-type="fig" rid="fig2">Figure 2C, D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>Rab5</italic> is a UBQLN2<sup>4XALS</sup> modifier gene.</title><p>(<bold>A</bold>) Genomic map of BSC37. The region spanning the <italic>Rab5</italic> gene is boxed. (<bold>B</bold>) Representative eye images from GMR&gt;UBQLN2<sup>4XALS</sup>/BSC37 and GMR&gt;UBQLN2<sup>4XALS</sup>/CyO flies. (<bold>C</bold>) Differential effects of Rab5 knockdown on GMR&gt;UBQLN2 eye phenotypes at 22°C and 29°C. Recombinant GMR&gt;UBQLN2 flies of indicated genotypes were crossed to flies expressing shRNAs targeting Rab5 (shRab5) or luciferase (shLuci). F1 progeny were processed for eye imaging 2–3 days after eclosion. (<bold>D, E</bold>) UBQLN2 expression levels in whole heads of GMR-Gal4, GMR&gt;UBQLN2<sup>WT</sup>, GMR&gt;UBQLN2<sup>P497H</sup>, or GMR&gt;UBQLN2<sup>4XALS</sup> flies on the genetic backgrounds of shLuci or shRab5. (<bold>E</bold>) Rab5 knockdown did not impact UBQLN2 expression. Quantification of UBQLN2 expression normalized to β-tubulin. The bars represent mean with <italic>SEM</italic> of triplicate samples. Unpaired t-test was used for statistical analysis. (<bold>F</bold>) GFP-Rab5 overexpression rescued the UBQLN2<sup>4XALS</sup> RE phenotype at 29°C. GMR&gt;UBQLN2 flies of indicated genotypes were crossed to flies harboring UAS-GFP or UAS-GFP-Rab5 transgenes. Eye degeneration scores are displayed below each eye image (<bold>B, C, F</bold>). (<bold>G, H</bold>) UBQLN2 expression levels in whole heads of GMR-Gal4, GMR&gt;UBQLN2<sup>WT</sup>, GMR&gt;UBQLN2<sup>P497H</sup>, or GMR&gt;UBQLN2<sup>4XALS</sup> flies on the genetic backgrounds of GFP or GFP-Rab5 overexpression. (<bold>H</bold>) Quantification of UBQLN2 expression normalized to β-tubulin. The bars represent mean with <italic>SEM</italic> of triplicate samples. Unpaired t-test was used for statistical analysis.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Uncropped Western blot images corresponding to <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D, E, G, H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig2-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Transcriptional elongation factor lilliputian (<italic>lilli</italic>) is a UBQLN2<sup>4XALS</sup> suppressor.</title><p>(<bold>A</bold>) Schematic of BSC180, ED4651, C144, and the <italic>lilli</italic> gene locus. (<bold>B</bold>) Reduced expression of lilli rescued the UBQLN2<sup>4XALS</sup> RE phenotype at 29°C. Representative eye phenotypes from GMR&gt;UBQLN2<sup>4XALS</sup> flies harboring the indicated alleles. Eye degeneration scores are displayed below each eye image. (<bold>C</bold>) UBQLN2 expression levels in whole heads of GMR&gt;UBQLN2<sup>4XALS</sup> flies on the genetic backgrounds of <italic>lilli</italic> mutation or CyO control. Quantification of UBQLN2 expression normalized to β-tubulin (right panel). The bars represent mean with <italic>SEM</italic> of triplicate samples. Unpaired t-test was used for statistical analysis.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Uncropped Western blot images corresponding to <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig2-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig2-figsupp2-v2.tif"/></fig></fig-group><p>The UBQLN2<sup>4XALS</sup> screen identified seven suppressors, three of which overlapped a common genomic interval, and 23 enhancers, including 15 lethal enhancers (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The UBQLN2<sup>P497H</sup> screen identified six enhancers, two of which were also identified in the UBQLN2<sup>4XALS</sup> screen (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Notably, all Dfs that enhanced the GMR&gt;UBQLN2<sup>P497H</sup> eye phenotype also caused enhanced eye phenotypes in GMR&gt;UBQLN2<sup>WT</sup> flies.</p><p>A combination of iterative Df screening and RNAi screening was then used to map causal genes within three UBQLN2<sup>4XALS</sup> suppressor loci (BSC180, ED2426, and Exel6038) and one enhancer locus common to UBQLN2<sup>4XALS</sup> and UBQLN2<sup>P497H</sup> (BSC37) (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). Among 17 annotated genes within BSC37 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>), we prioritized <italic>Rab5</italic>, which encodes an early endosomal protein that interacts with the ALS2 gene product, Alsin (<xref ref-type="bibr" rid="bib31">Hsu et al., 2018</xref>; <xref ref-type="bibr" rid="bib41">Kunita et al., 2007</xref>). In support of a role for <italic>Rab5</italic> as a UBQLN2 modifier gene, <italic>Rab5</italic> knockdown phenocopied the hyperpigmented phenotype seen in GMR&gt;UBQLN2<sup>4XALS</sup> flies crossed to BSC37 at 29°C (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B, C</xref>). <italic>Rab5</italic> knockdown also caused a hyperpigmented eye phenotype in GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>P497H</sup> flies (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>), indicating <italic>Rab5</italic> is a mutation-independent UBQLN2 enhancer. Interestingly, while <italic>Rab5</italic> knockdown also caused hyperpigmented eye patches in GMR&gt;UBQLN2<sup>WT</sup>, and GMR&gt;UBQLN2<sup>P497H</sup> flies reared at 22°C, GMR&gt;UBQLN2<sup>4XALS</sup>/shRab5 flies reared at 22°C failed to exhibit eye patches (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). This finding supports the idea that UBQLN2<sup>4XALS</sup> phenotypes are HS dependent and is consistent with an earlier study showing stronger eye phenotypes in GMR&gt;UBQLN2<sup>WT</sup> and GMR&gt;UBQLN2<sup>P497H</sup> flies relative to GMR&gt;UBQLN2<sup>4XALS</sup> flies at 22°C (<xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>). Finally, we showed that overexpression of GFP-Rab5 partially rescued the eye phenotype of GMR&gt;UBQLN2<sup>WT</sup>, GMR&gt;UBQLN2<sup>P497H</sup>, and GMR&gt;UBQLN2<sup>4XALS</sup> flies reared at 29°C (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>). Rab5 knockdown or overexpression did not affect UBQLN2 expression (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D, E, G, H</xref>). The combined findings suggest that <italic>Rab5</italic> is a general modulator of UBQLN2 toxicity and that UBQLN2 overexpression interferes with endolysosomal function in flies.</p><p>A similar approach was used to map the causal UBQLN2<sup>4XALS</sup> suppressor gene in BSC180. Two different overlapping Dfs (C144 and ED4651) rescued UBQLN2<sup>4XALS</sup> eye toxicity to a similar extent as BSC180 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A, B</xref>). Within this overlap we identified <italic>lilliputian</italic> (<italic>lilli</italic>) as a gene of interest. <italic>lilli</italic> encodes a transcriptional elongation factor that is orthologous to mammalian <italic>AF4/FMR2</italic> (fragile X mental retardation 2) (<xref ref-type="bibr" rid="bib92">Wittwer et al., 2001</xref>). Interestingly, <italic>lilli</italic> mutations were recently shown to suppress toxicity of TDP-43 and <italic>C9ORF72</italic>-derived dipeptide repeat proteins (DPRs) in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib14">Chung et al., 2018</xref>; <xref ref-type="bibr" rid="bib95">Yuva-Aydemir et al., 2019</xref>). In support of <italic>lilli</italic> as a UBQLN2<sup>4XALS</sup> suppressor, a <italic>lilli<sup>A1</sup></italic><sup>7-2</sup> LOF allele diminished UBQLN2<sup>4XALS</sup>-mediated eye toxicity to a similar extent as <italic>lilli</italic>-spanning Dfs (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B, C</xref>). Thus, <italic>lilli</italic> may be of interest as a general suppressor of toxicity arising from misexpression of neurodegeneration-associated genes in <italic>Drosophila</italic>.</p></sec><sec id="s2-4"><title><italic>Unc-5</italic> mutations suppress UBQLN2 toxicity</title><p>Next, we mapped a UBQLN2<sup>4XALS</sup> suppressor in the genetic interval spanned by ED2426 and BSC346, which suppressed GMR&gt;UBQLN2<sup>4XALS</sup> eye phenotypes to a similar extent (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). The region of overlap between ED2426 and BSC346 contains <italic>Unc-5</italic>, which encodes a transmembrane dependence receptor that mediates axonal repulsion and apoptosis suppression in response to secreted netrin ligands (<xref ref-type="bibr" rid="bib8">Boyer and Gupton, 2018</xref>; <xref ref-type="bibr" rid="bib43">Labrador et al., 2005</xref>; <xref ref-type="bibr" rid="bib36">Keleman and Dickson, 2001</xref>; <xref ref-type="bibr" rid="bib55">Llambi et al., 2005</xref>; <xref ref-type="bibr" rid="bib87">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="bib3">Ahn et al., 2020</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Disruption of <italic>Unc-5</italic> suppresses UBQLN2-associated eye degeneration.</title><p>(<bold>A</bold>) Schematic depiction of ED2426 and overlapping deficiencies (Dfs) in relation to the <italic>Unc-5</italic> gene locus. (<bold>B</bold>) Representative eye images of GMR&gt;UBQLN2<sup>4XALS</sup> flies crossed to Df lines ED2426 and BSC346. (<bold>C</bold>) Single allele expression of <italic>Unc-5</italic> LOF alleles (left panels) or three independent <italic>Unc-5</italic> RNAi alleles diminished the rough eye (RE) phenotype of GMR&gt;UBQLN2<sup>4XALS</sup> flies at 29°C. (<bold>D, E</bold>) UBQLN2 expression levels in whole heads of GMR&gt;UBQLN2<sup>4XALS</sup> flies on the indicated genetic backgrounds. (<bold>E</bold>) Quantification of UBQLN2 expression normalized to β-tubulin. The bars represent mean with <italic>SEM</italic> of triplicate samples. Unpaired t-test was used for statistical analysis. (<bold>F</bold>) <italic>fra</italic> silencing reduced the RE phenotype of GMR&gt;UBQLN2<sup>4XALS</sup> flies. Shown are representative eye phenotypes of F1 progeny from GMR&gt;UBQLN2<sup>4XALS</sup> flies crossed to control (shLuci, shmCherry), or <italic>fra</italic> RNAi lines at 29°C. Eye degeneration scores are displayed below each eye image (<bold>B, C, F</bold>).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Uncropped Western blot images corresponding to <xref ref-type="fig" rid="fig3">Figure 3D, E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Unc-5</italic> silencing does not modify FUS-associated eye degeneration.</title><p>Representative eye images of GMR&gt;eGFP (control), GMR&gt;FUS<sup>WT</sup>, GMR&gt;FUS<sup>R518K</sup>, or GMR&gt;FUS<sup>R521C</sup> flies harboring the indicated shRNA alleles. Eye degeneration scores are displayed below each eye image.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig3-figsupp1-v2.tif"/></fig></fig-group><p>In support of a genetic interaction between <italic>Unc-5</italic> and UBQLN2<sup>4XALS</sup>, two <italic>Unc-5</italic> LOF alleles (<xref ref-type="bibr" rid="bib43">Labrador et al., 2005</xref>), and three different RNAi lines diminished the RE phenotype of GMR&gt;UBQLN2<sup>4XALS</sup> flies without affecting UBQLN2 expression (<xref ref-type="fig" rid="fig3">Figure 3C, D and E</xref>). By contrast, <italic>Unc-5</italic> knockdown had no effect on the RE phenotype caused by the expression of ALS-associated FUS alleles that cause severe degenerative phenotypes in <italic>Drosophila</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib44">Lanson et al., 2011</xref>; <xref ref-type="bibr" rid="bib42">Kwiatkowski et al., 2009</xref>; <xref ref-type="bibr" rid="bib84">Vance et al., 2009</xref>). This suggests that genetic interaction with <italic>Unc-5</italic> may be specific to UBQLN2 versus other ectopically expressed ALS-associated proteins in <italic>Drosophila</italic>.</p><p>The repulsive activity of <italic>Unc-5</italic> on axon guidance is antagonized by <italic>frazzled (fra),</italic> which encodes the fly ortholog of mammalian <italic>deleted in colon carcinoma</italic> (<italic>DCC</italic>) (<xref ref-type="bibr" rid="bib11">Chan et al., 1996</xref>; <xref ref-type="bibr" rid="bib35">Keino-Masu et al., 1996</xref>; <xref ref-type="bibr" rid="bib39">Kolodziej et al., 1996</xref>). <italic>fra</italic> silencing by two different RNAi lines rescued the UBQLN2<sup>4XALS</sup> eye phenotype to a similar extent as <italic>Unc-5</italic> knockdown (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). The combined findings suggest that signaling through Unc-5/Frazzled potentiates UBQLN2<sup>4XALS</sup> toxicity in the <italic>Drosophila</italic> compound eye.</p><p>To evaluate the impact of <italic>Unc-5</italic> silencing on motor function, we measured climbing behavior of recombinant flies expressing UBQLN2<sup>4XALS</sup> under control of a D42 motor neuron driver in the presence of shUnc-5 or control shRNAs at 29°C. The moderate climbing defect of D42&gt;UBQLN2<sup>4XALS</sup> flies relative to D42-Gal4 flies was partially reversed by an shUnc-5 (TRiP) allele in both male and female flies, while a second <italic>Unc-5</italic> shRNA line (KK) rescued climbing in male but not female flies (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Unc-5</italic> silencing in <italic>Drosophila</italic> suppressed UBQLN2<sup>4XALS</sup>-associated neuronal phenotypes.</title><p>(<bold>A</bold>) Recombinant D42&gt;UBQLN2<sup>4XALS</sup> flies expressing UBQLN2 under control of the motor neuron-specific D42 driver were crossed to the indicated RNAi lines. Climbing potential of male (left) and female (right) progeny reared at 29°C was measured 7 days after eclosion as described in Materials and methods. Data analysis was performed using ordinary one-way ANOVA. Data are shown as mean ± SEM. n&gt;100 flies, ****p≤0.0001. (<bold>B</bold>) Neuromuscular junction (NMJ) morphology analysis of D42&gt;UBQLN2<sup>4XALS</sup> larvae expressing the indicated shRNAs. NMJs dissected from third instar larvae were stained with α-HRP and α-CSP antibodies and imaged by confocal microscopy. Scale bar: 10μm. (<bold>C</bold>) Number of NMJs harboring indicated phenotypes were tabulated from greater than 50 NMJs per genotype. Unpaired t-test was used for statistical analysis. Data are shown as mean ± SEM. (<bold>D</bold>) Pan-neuronal <italic>Unc-5</italic> knockdown enhances lifespan of Elav&gt;UBQLN2<sup>4XALS</sup> flies. Recombinant Elav&gt;UBQLN2<sup>4XALS</sup> or a Elav&gt;Gal4 flies were crossed to the indicated RNAi lines (shLuci or shUnc5). Lifespan of male (left panel) and female (right panel) progeny reared at 27°C was measured as described in Materials and methods. n&gt;50 flies.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Data sets corresponding to <xref ref-type="fig" rid="fig4">Figure 4A, C, D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig4-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig4-v2.tif"/></fig><p>Consistent with their climbing defects, D42&gt;UBQLN2<sup>4XALS</sup> flies exhibited neuromuscular junction (NMJ) abnormalities, including increased numbers of satellite boutons and reduced numbers of mature boutons. Both phenotypes were corrected by <italic>Unc-5</italic> silencing (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>). Finally, we also measured the effect of <italic>Unc-5</italic> silencing on lifespans of flies expressing UBQLN2<sup>4XALS</sup> under control of a pan-neuronal Elav driver. Elav&gt;UBQLN2<sup>4XALS</sup>/shUnc-5 flies showed a significant increase in lifespan relative to Elav&gt;UBQLN2<sup>4XALS</sup> flies crossed to shLuci, with the effect being most pronounced in female flies (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). <italic>Unc-5</italic> knockdown also modestly increased the lifespan of Elav-Gal4 male flies relative to Elav-Gal4/shLuci flies while having no impact on lifespan of Elav-Gal4 female flies (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Altogether, these experiments suggest that aberrant Unc-5 signaling contributes to neuronal phenotypes in UBQLN2<sup>4XALS</sup> flies.</p></sec><sec id="s2-5"><title>The motor neuron guidance factor <italic>beat-1b</italic> suppresses UBQLN2<sup>4XALS</sup> eye toxicity</title><p>The identification of <italic>Unc-5</italic> as a UBQLN2<sup>4XALS</sup> suppressor raised the possibility that axonal guidance defects are particularly relevant to the UBQLN2 toxicity mechanism. Interestingly, the overlapping genetic interval spanned by the UBQLN2<sup>4XALS</sup> suppressors Exel6038 and r10 contains <italic>beat-1b</italic> and <italic>beat-1c</italic>, two members of the <italic>beaten path</italic> (<italic>beat</italic>) family of axon guidance genes (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>; <xref ref-type="bibr" rid="bib83">Vactor et al., 1993</xref>). Neuronally expressed Beat proteins regulate motor axon guidance and defasciculation in response to Sidestep (Side) ligands expressed on target substrates (<xref ref-type="bibr" rid="bib22">Fambrough and Goodman, 1996</xref>; <xref ref-type="bibr" rid="bib78">Sink et al., 2001</xref>; <xref ref-type="bibr" rid="bib77">Siebert et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">de Jong et al., 2005</xref>). UBQLN2<sup>4XALS</sup> flies crossed to a Beat-1b shRNA line exhibited less severe eye degeneration than UBQLN2<sup>4XALS</sup> flies expressing shRNAs targeting luciferase, mCherry, or <italic>beat-1c</italic> (<xref ref-type="fig" rid="fig5">Figure 5D, E and F</xref>). GMR&gt;UBQLN2<sup>4XALS</sup> flies heterozygous for a p-element insertion in the <italic>beat-1b</italic> ORF also exhibited improved eye phenotype relative to control GMR&gt;UBQLN2<sup>4XALS</sup> controls (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). These findings support the idea that Beat-1b signaling contributes to UBQLN2 toxicity and further implicate axonal guidance defects as a contributing pathomechanism to UBQLN2-associated neurodegeneration.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The axon guidance gene <italic>beat-1b</italic> is a UBQLN2<sup>4XALS</sup> suppressor.</title><p>(<bold>A</bold>) Schematic of the <italic>beat-1b</italic> gene locus. (<bold>B</bold>) Representative eye phenotypes of GMR&gt;UBQLN2<sup>4XALS</sup> flies harboring the indicated deficiency (Df) alleles. (<bold>C</bold>) UBQLN2 expression levels and RIPA solubility in whole heads of GMR&gt;UBQLN2<sup>4XALS</sup>/Exel6038 and GMR&gt;UBQLN2<sup>4XALS</sup>/CyO flies. (<bold>D</bold>) Representative eye phenotypes of GMR&gt;UBQLN2<sup>4XALS</sup> flies expressing the indicated shRNAs. Eye degeneration scores are displayed below each eye image (<bold>B, D</bold>). (<bold>E, F</bold>) Knockdown of Beat-1b or Beat-1c does not inhibit UBQLN2 expression in GMR&gt;UBQLN2<sup>4XALS</sup> flies. (<bold>F</bold>) Quantification of UBQLN2 expression normalized to β-tubulin. The bars represent mean with <italic>SEM</italic> of triplicate samples. Unpaired t-test was used for statistical analysis. .</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Uncropped Western blot images corresponding to <xref ref-type="fig" rid="fig5">Figure 5C, E, F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig5-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig5-v2.tif"/></fig></sec><sec id="s2-6"><title>iPSC models for UBQLN2-associated ALS</title><p>We employed CRISPR/CAS9 to introduce ALS-associated mutations into the X-linked <italic>UBQLN2</italic> gene in neonatal male induced pluripotent stem cells (iPSCs) (WC031i-5907-6, see Materials and methods, and <xref ref-type="bibr" rid="bib20">Du et al., 2015</xref>). During the course of this work, we serendipitously derived an <italic>UBQLN2</italic> allele harboring clinical P497H and P525S mutations (termed UBQLN2<sup>2XALS</sup>) as well as a UBQLN2<sup>I498X</sup> allele that truncated the UBQLN2 ORF at codon 498 within the PRR. The expression and RIPA solubility of UBQLN2<sup>P497H</sup>, UBQLN2<sup>2XALS</sup>, and UBQLN2<sup>4XALS</sup> were comparable to UBQLN2<sup>WT</sup> in undifferentiated iPSCs, while UBQLN2<sup>I498X</sup> could not be detected by Western blotting suggesting it is a null allele (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). We also failed to detect cytologic UBQLN2<sup>P497H</sup>, or UBQLN2<sup>4XALS</sup> aggregates in immunostaining experiments, indicating that endogenous ALS mutations are insufficient to promote UBQLN2 aggregation in undifferentiated iPSCs (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). As expected, UBQLN2<sup>I498X</sup> iPSCs exhibited very weak immunoreactivity with UBQLN2 antibodies.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Localization and solubility of UBQLN2<sup>ALS</sup> mutants in induced pluripotent stem cells (iPSCs).</title><p>(<bold>A</bold>) Extracts from UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, UBQLN2<sup>2XALS</sup>, UBQLN2<sup>I498X</sup>, or UBQLN2<sup>4XALS</sup> iPSCs (clone 1 [C1] and clone 2 [C2]) were separated into soluble and insoluble fractions in 1% Triton X-100 (TX-100) buffer and immunoblotted with α-UBQLN2, and α-β-tubulin antibodies. (<bold>B</bold>) Localization patterns of wild-type and UBQLN2<sup>ALS</sup> proteins in iPSCs. UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, UBQLN2<sup>4XALS</sup>, and UBQLN2<sup>I498X</sup> iPSCs were stained with α-UBQLN2 and α-TIAR antibodies and imaged by confocal microscopy. Note the lack of cytosolic aggregates. (<bold>C</bold>) Cell extracts from iPSCs of the indicated genotypes were incubated at room temperature with increasing amounts of chymotrypsin for 5 min. After separation by SDS-PAGE, the proteins were immunoblotted with α-UBQLN2 antibodies. Positions of full-length and cleaved UBQLN2 are denoted by arrows. *: non-specific band. (<bold>D</bold>) Autophagy inhibition with BafA1 reduced solubility of endogenous UBQLN2<sup>ALS</sup> proteins. UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, UBQLN2<sup>4XALS</sup>, and UBQLN2<sup>I498X</sup> iPSCs were treated with 100 nM of BafA1 for 16 hr followed by BafA1 washout and incubation in BafA1-free growth media for 8 hr. Detergent extracts were separated into soluble and insoluble fractions and analyzed by SDS-PAGE and immunoblotting using UBQLN2, UBQLN1, LC3A/B, and β-tubulin antibodies. (<bold>E</bold>) Quantification of UBQLN2 solubility in UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> iPSCs from (<bold>D</bold>). The bars represent mean with <italic>SEM</italic> of triplicate samples. Unpaired t-test was used for statistical analysis. *p≤0.05, ***p≤0.001.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Uncropped Western blot images corresponding to <xref ref-type="fig" rid="fig6">Figure 6A, C, D, E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig6-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Endogenous UBQLN2<sup>ALS</sup> mutants perturb lysosomes.</title><p>(<bold>A</bold>) UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, UBQLN2<sup>4XALS</sup>, and UBQLN2<sup>I498X</sup> induced pluripotent stem cells (iPSCs) were treated with 100 nM of BafA1 for 16 hr and processed for immunostaining with UBQLN2 and Lamp1 antibodies. Arrowheads indicate colocalization of UBQLN2 and Lamp1. (<bold>B</bold>) UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, UBQLN2<sup>4XALS</sup>, and UBQLN2<sup>I498X</sup> iPSCs were immunostained with UBQLN2 and Rab5 antibodies after incubation in 100 nM BafA1 for 16 hr. (<bold>C, D</bold>) Increased lysosomal size and number in UBQLN2<sup>ALS</sup> mutant iPSCs. (<bold>C</bold>) Representative images from UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, UBQLN2<sup>4XALS</sup>, and UBQLN2 <sup>I498X</sup> iPSCs following labeling with LysoTracker Red DND-99 for 1 hr and costaining with Hoechst 33342. Scale bar: 10μm. (<bold>D</bold>) Size and numbers of LysoTracker-positive compartments were analyzed on a per cell basis using Fiji. Unpaired t-test was used for statistical analysis. Data are shown as mean ± SEM. *p≤0.05, ***p≤0.001, ****p≤0.0001.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Data sets corresponding to <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C, D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig6-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig6-figsupp1-v2.tif"/></fig></fig-group><p>Previous work demonstrated that the 4XALS mutation increased the chymotrypsin sensitivity of purified UBQLN2, likely due to defective folding of the PRR (<xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>). To determine whether the 4XALS mutation altered the folding of endogenous UBQLN2, we incubated detergent extracts from UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, UBQLN2<sup>4XALS</sup> iPSCs with increasing concentrations of chymotrypsin. As shown in <xref ref-type="fig" rid="fig6">Figure 6C</xref>, UBQLN2<sup>4XALS</sup> exhibited a unique chymotryptic fragmentation pattern relative to UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup>, suggesting that endogenous UBQLN2<sup>4XALS</sup> is misfolded.</p><p>Reasoning that transient inhibition of protein degradation may potentiate UBQLN2 aggregation, we prepared soluble and insoluble fractions of UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> iPSCs exposed to the proteasome inhibitor MG132 or the autophagy inhibitor bafilomycin A1 (BafA1). While MG132 had no effect (not shown), BafA1 decreased the solubility of both wild-type and mutant UBQLN2 proteins, with the effect being most pronounced for UBQLN2<sup>4XALS</sup> (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). In addition, while the solubility of UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> recovered following BafA1 washout, the fraction of insoluble UBQLN2<sup>4XALS</sup> remained elevated (<xref ref-type="fig" rid="fig6">Figure 6D and E</xref>). Finally, the relative abundance of lipidated and non-lipidated forms of LC3 were comparable between UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup>, and UBQLN2<sup>I498X</sup> iPSCs, suggesting similar levels of autophagic flux (<xref ref-type="fig" rid="fig6">Figure 6D</xref>).</p><p>We next evaluated the localization of wild-type and ALS-mutant UBQLN2 proteins to endolysosomal structures. UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> partially localized with the lysosomal marker LAMP1 in BafA1-treated iPSCs (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). By contrast, UBQLN2 punctae did not significantly overlap with Rab5-positive endosomes (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). Given colocalization of UBQLN2 with LAMP1, we evaluated impacts of P497H and 4XALS mutations on lysosomal number and size in live cells using the lysosome-tropic fluorescent probe, LysoTracker. Both the abundance and average size of lysosomes were significantly elevated in UBQLN2<sup>P497H</sup> and UBQLN2<sup>4XALS</sup> iPSCs, relative to UBQLN2<sup>WT</sup> or UBQLN2<sup>I498X</sup> iPSCs, which exhibited qualitatively similar LysoTracker staining patterns (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). In particular, the frequency of lysosomes greater than 5 μm and 10 μm was significantly elevated in UBQLN2<sup>4XALS</sup> iPSCs versus UBQLN2<sup>P497H</sup> iPSCs (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). These findings support the existence of endolysosomal defects in UBQLN2<sup>ALS</sup> iPSCs.</p></sec><sec id="s2-7"><title>UBQLN2<sup>ALS</sup> iMNs exhibit axonal inclusions and neurite defects</title><p>A failure to detect UBQLN2<sup>ALS</sup> aggregates in untreated iPSCs could be due to continuous cytosolic dilution of UBQLN2 during mitotic cell division or may reflect the absence of neuron-specific stimuli that promote UBQLN2 aggregation. To explore these ideas, we carried out immunostaining experiments using UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, or UBQLN2<sup>4XALS</sup> iMNs (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup> showed largely diffuse localization patterns, whereas UBQLN2<sup>4XALS</sup> formed discrete aggregates distributed throughout iMN cell bodies and axons (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). UBQLN2 aggregation was also observed in iMNs differentiated from an independently generated UBQLN2<sup>4XALS</sup> iPSC clone (Clone 2, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Protein aggregation and neurite defects in UBQLN2<sup>ALS</sup> inducible motor neurons (iMNs).</title><p>(<bold>A</bold>) UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> iMNs were immunostained for UBQLN2 and Tuj1. Magnified images of UBQLN2<sup>4XALS</sup> iMN soma (<bold>i</bold>), axons (ii), and neurite terminals (iii) are shown; aggregates are marked with arrows. (<bold>B</bold>) UBQLN2 localizes to growth cone lamellipodia and filopodia. Differentiated iMNs of the indicated genotypes were costained for UBQLN2, Tuj1, and filamentous actin (phalloidin). Note reduced complexity of the UBQLN2<sup>4XALS</sup> growth cone. Arrowheads indicate UBQLN2<sup>4XALS</sup> aggregates. Scale bars = 10 μm. (<bold>C</bold>) Schematic of Sholl analysis. Tracing example of an iMN (<bold>i</bold>) displays the paths representing individual neuron structure, with nodes (N<sub>i</sub>) and edges (E<sub>j</sub>) corresponding to the dendrogram on (ii) and (iii). (<bold>D</bold>) UBQLN2<sup>4XALS</sup> iMNs exhibit reduced complexity. UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> iMNs were stained with α-Tuj1 and imaged by confocal microscopy. One hundred neurons of the indicated genotypes were traced using Simple Neurite Tracer (SNT) and subjected to Sholl image analysis to quantify total neurite projection path length (<bold>i</bold>), primary neurite length (ii), terminal neurite length (iii), neurite branch points (iv), and Sholl decay (<bold>v</bold>). Data analysis was performed using ordinary one-way ANOVA. Data are shown as mean ± SEM. n&gt;100 iMNs, **p≤0.01, ****p≤0.0001.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Data sets corresponding to <xref ref-type="fig" rid="fig7">Figure 7D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig7-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Protein aggregation and reduced neurite complexity in an independent UBQLN2<sup>4XALS</sup> inducible motor neuron (iMN) line.</title><p>(<bold>A</bold>) UBQLN2<sup>4XALS</sup> (<bold>C2</bold>) iMNs were immunostained for UBQLN2 and Tuj1. Aggregates are marked with arrowheads. (<bold>B</bold>) Growth cone morphologies in UBQLN2<sup>4XALS</sup> (<bold>C2</bold>) iMNs. iMNs were stained with α-UBQLN2, α-Tuj1, and phalloidin. Note reduced growth cone elaboration in UBQLN2<sup>4XALS</sup> (<bold>C2</bold>) iMNs. Scale bars = 10 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>The UBQLN2<sup>4XALS</sup> mutation did not significantly impact the localization of DCC.</title><p>Inducible motor neurons (iMNs) of the indicated genotypes were immunostained with α-UBQLN2 and α-DCC antibodies, and phalloidin. Scale bars = 10 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig7-figsupp2-v2.tif"/></fig></fig-group><p>F-actin labeling with phalloidin revealed that UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> were evenly distributed throughout growth cone lamellipodia and filopodia. Lamellipodial UBQLN2<sup>4XALS</sup> staining was generally weaker, except for occasional brightly staining aggregates that were observed in ~50% of growth cones examined (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Notably, the UBQLN2<sup>4XALS</sup> mutation did not significantly impact the localization of DCC, which was highly enriched in filopodial spikes in iMNs of all UBQLN2 genotypes (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>).</p><p>We evaluated neurite length and complexity in UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> iMNs using Sholl analyses according to the diagram shown in <xref ref-type="disp-formula" rid="equ1">Equation 1</xref> and <xref ref-type="fig" rid="fig7">Figure 7C</xref>, respectively. UBQLN2<sup>4XALS</sup> iMNs exhibited a significant reduction in average total neurite length, primary neurite length, and neurite branch length relative to UBQLN2<sup>WT</sup> iMNs, which manifested as an increased rate of Sholl decay (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). By contrast, neurite length and complexity were comparable between UBQLN2<sup>P497H</sup> and UBQLN2<sup>WT</sup> iMNs, indicating the clinical P497H mutation is insufficient to disrupt neurite growth dynamics (<xref ref-type="fig" rid="fig7">Figure 7D</xref>).</p><p>Given that autophagy inhibition with BafA1 induced UBQLN2<sup>4XALS</sup> aggregation in iPSCs, we carried out similar studies in UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> iMNs. BafA1 strongly increased the size and number of UBQLN2<sup>4XALS</sup> aggregates while having minimal effects on UBQLN2<sup>WT</sup> or UBQLN2<sup>P497H</sup> localization. BafA1-induced UBQLN2<sup>4XALS</sup> aggregates were observed in two different iMN clones and were strongly colocalized with the autophagy receptor, p62 (<xref ref-type="fig" rid="fig8">Figure 8A, B and D</xref>). In addition, UBQLN2<sup>4XALS</sup> aggregates often colocalized with, or were adjacent to, LAMP1-positive lysosomes (<xref ref-type="fig" rid="fig8">Figure 8C and D</xref>). By contrast, UBQLN2<sup>4XALS</sup> only weakly colocalized with endosomal Rab5 or the autophagosome marker, LC3 (<xref ref-type="fig" rid="fig8">Figure 8C and D</xref>). These findings suggest that the autophagy pathway suppresses endogenous UBQLN2<sup>4XALS</sup> aggregation in iMNs.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>BafA1 induces p62-positive UBQLN2<sup>4XALS</sup> aggresomes in inducible motor neurons (iMNs).</title><p>(<bold>A</bold>) UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> iMNs were treated with BafA1 (50 nM) for 16 hr and processed for immunostaining with UBQLN2 and p62. Arrowheads indicate UBQLN2<sup>4XALS</sup> aggregates that were colocalized with p62. (<bold>B</bold>) The number of UBQLN2<sup>4XALS</sup> aggregates was analyzed on a per cell basis using Fiji. Data analysis was performed using ordinary one-way ANOVA. Data are shown as mean ± SEM. n&gt;50 iMNs, ****p≤0.0001. (<bold>C</bold>) UBQLN2<sup>4XALS</sup> iMNs were treated with BafA1 and processed for immunostaining with UBQLN2 and Lamp1, Rab5, or LC3. Arrowheads indicate UBQLN2<sup>4XALS</sup> colocalization with Lamp1. Scale bars = 10 μm. (<bold>D</bold>) Pearson’s correlation coefficients for colocalization assays. Pearson’s coefficients were plotted as a bar graph to compare the colocalization of UBQLN2 with p62, LAMP1, Rab5, or LC3. n=10 iMNs, Error bars represent SEM, ****p≤0.0001 (ordinary one-way ANOVA).</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Data sets corresponding to <xref ref-type="fig" rid="fig8">Figure 8B, D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig8-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig8-v2.tif"/></fig></sec><sec id="s2-8"><title>UNC5B and DCC silencing reduce neurite and growth cone defects in UBQLN2<sup>4XALS</sup> iMNs</title><p>Mammals harbor a single <italic>fra</italic> ortholog, <italic>DCC</italic>, and four closely related paralogs with homology to <italic>Unc-5: UNC5A, UNC5B, UNC5C,</italic> and <italic>UNC5D</italic>. Among these, we focused on <italic>UNC5B</italic>, which is widely expressed in nervous tissue and has well-described roles in axon guidance and apoptosis regulation (<xref ref-type="bibr" rid="bib87">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="bib3">Ahn et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Pradella et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Tang et al., 2008</xref>). To assess contributions of DCC and UNC5B signaling to UBQLN2-associated toxicity, we transduced UBQLN2<sup>4XALS</sup> iPSCs with lentiviral shRNA vectors targeting DCC or UNC5B and differentiated the cells into iMNs for neurite analysis. qPCR confirmed that expression of UNC5B and DCC was reduced ~40–60% in their respective shRNA-transduced iPSCs relative to iPSCs transduced with an NT shRNA vector (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1A, B</xref>). UBQLN2<sup>4XALS</sup> iMNs expressing <italic>DCC</italic> shRNA also showed reduced DCC immunoreactivity at filopodial spikes (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1C</xref>). Both <italic>UNC5B</italic> and <italic>DCC</italic> knockdown significantly increased average total neurite length, primary neurite length, and branch length in UBQLN2<sup>4XALS</sup> iMNs relative to UBQLN2<sup>4XALS</sup> iMNs expressing a non-targeting (NT) control shRNA (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). Neither <italic>UNC5B</italic> nor <italic>DCC</italic> silencing affected the size or number of UBQLN2<sup>4XALS</sup> aggregates (<xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2</xref>), suggesting they influence toxicity pathway(s) downstream of UBQLN2 aggregation.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>UNC5B and DCC silencing partially reverse neurite and growth cone defects in UBQLN2<sup>4XALS</sup> inducible motor neurons (iMNs).</title><p>(<bold>A</bold>) UBQLN2<sup>4XALS</sup> iMNs expressing shNT, shUNC5B, or shDCC were subjected to Sholl analysis of neurite length and complexity as described in <xref ref-type="fig" rid="fig7">Figure 7</xref>. Data analysis was performed using ordinary one-way ANOVA. Data are shown as mean ± SEM. n&gt;100 iMNs, *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001. (<bold>B</bold>) Growth cone morphologies in UBQLN2<sup>4XALS</sup> iMNs. UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup> iMNs. iMNs of the indicated genotypes were stained with α-UBQLN2, α-Tuj1, and phalloidin. Note reduced growth cone elaboration in UBQLN2<sup>4XALS</sup> iMNs. (<bold>C</bold>) Enhanced growth cone elaboration in UBQLN2<sup>4XALS</sup> iMNs expressing DCC or UNC5B shRNAs. iMNs of the indicated genotype were stained with α-UBQLN2, α-Tuj1, and phalloidin. Arrowheads denote growth cones. (<bold>D</bold>) Quantification of growth cones in UBQLN2<sup>WT</sup>, UBQLN2<sup>P497H</sup>, and UBQLN2<sup>4XALS</sup>, and UBQLN2<sup>4XALS</sup> iMNs expressing the indicated shRNAs. Data analysis was performed using ordinary one-way ANOVA. Data are shown as mean ± SEM. n&gt;100 iMNs, *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.</p><p><supplementary-material id="fig9sdata1"><label>Figure 9—source data 1.</label><caption><title>Data sets corresponding to <xref ref-type="fig" rid="fig9">Figure 9A, D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig9-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>Expression of UNC5B and DCC mRNA in UBQLN2<sup>4XALS</sup> induced pluripotent stem cells (iPSCs) transduced with lentiviral shRNA vectors.</title><p>mRNA levels of UNC5B (<bold>A</bold>) and DCC (<bold>B</bold>) were analyzed by RT-qPCR in iPSCs expressing the indicated shRNAs. The bars represent mean with <italic>SEM</italic> of triplicate samples. Unpaired t-test was used for statistical analysis. *p≤0.05, **p≤0.01. (<bold>C</bold>) Inducible motor neurons (iMNs) of the indicated genotypes were immunostained with α-DCC antibodies. Note reduced filopodial DCC signal intensity in UBQLN2<sup>4XALS</sup>: shDCC iMNs.</p><p><supplementary-material id="fig9s1sdata1"><label>Figure 9—figure supplement 1—source data 1.</label><caption><title>Data sets corresponding to <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1A, B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-84382-fig9-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig9-figsupp1-v2.tif"/></fig><fig id="fig9s2" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 2.</label><caption><title>UNC5B or DCC knockdown does not affect UBQLN2<sup>4XALS</sup> aggregation in inducible motor neurons (iMNs).</title><p>UNC5B (<bold>A</bold>) or DCC (<bold>B</bold>) knockdown iMNs were immunostained with α-UBQLN2 antibodies. Aggregates are marked with arrowheads.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig9-figsupp2-v2.tif"/></fig></fig-group><p>We next evaluated growth cone morphology in wild-type and UBQLN2<sup>ALS</sup> iMNs stained with phalloidin. Compared to UBQLN2<sup>WT</sup> or UBQLN2<sup>P497H</sup> iMNs, UBQLN2<sup>4XALS</sup> iMNs showed a high proportion of blunt-end termini versus growth cone termini, suggesting a defect in growth cone elaboration (<xref ref-type="fig" rid="fig9">Figure 9B and D</xref>). A preponderance of blunt-end termini was also observed in UBQLN2<sup>4XALS</sup> (Clone 2) iMNs, suggesting they are a specific consequence of the 4XALS mutation (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). By contrast, UBQLN2<sup>4XALS</sup> iMNs expressing UNC5B or DCC shRNAs exhibited supernumerary growth cones along primary and secondary neurites and an increase in growth cone size and abundance relative to blunt-end termini (<xref ref-type="fig" rid="fig9">Figure 9C and D</xref>). These findings suggest that aberrant DCC-UNC5 signaling suppresses growth cone elaboration in UBQLN2<sup>4XALS</sup> iMNs and that axon guidance defects contribute to toxicity phenotypes in fly and iMN models for UBQLN2-associated ALS.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study we investigated how ALS-associated mutations in the Ub chaperone UBQLN2 cause cellular toxicity in <italic>Drosophila</italic> and gene-edited iMNs. Our findings support roles for endolysosomal dysfunction and axonal guidance defects as disease drivers in UBQLN2-associated ALS (<xref ref-type="fig" rid="fig10">Figure 10</xref>).</p><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>Speculative model for UBQLN2<sup>ALS</sup> toxicity suppression through the UNC5 pathway.</title><p>(Left panel) Wild-type motor neurons exhibit healthy neurites and well-elaborated growth cones devoid of UBQLN2 aggregates. (Center panel) Amyotrophic lateral sclerosis (ALS)-associated mutations in the proline-rich repeat (PRR) of UBQLN2 promote its misfolding and assembly into aggregates that trigger UNC5/DCC-dependent axonal retraction. UBQLN2<sup>ALS</sup> aggregates may directly initiate pathologic UNC5/DCC signaling or impact other aspects of cellular regulation, including the endolysosomal-autophagosomal pathway, leading to proteostasis deregulation and growth cone retraction. (Right panel) Suppression of UNC5/DCC signaling with rationally designed antibodies or small molecules (not shown) rescues growth cone defects in UBQLN2<sup>ALS</sup> motor neurons.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-84382-fig10-v2.tif"/></fig><p>A genetic Df screen in <italic>Drosophila</italic> identified 35 loci (7 suppressors and 28 enhancers) that influenced toxicity of UBQLN2<sup>ALS</sup> mutants. Key to the identification of phenotypic suppressors was a UBQLN2<sup>4XALS</sup> allele that showed elevated HS-dependent toxicity relative to UBQLN2<sup>ALS</sup> point mutants, whose toxicities were difficult to discern from overexpressed UBQLN2<sup>WT</sup> (<xref ref-type="fig" rid="fig1">Figures 1B</xref> and <xref ref-type="fig" rid="fig2">2D</xref>). The reason for enhanced toxicity of UBQLN2<sup>4XALS</sup> is unclear; however, its enhanced aggregation potential may overwhelm cellular proteostasis machinery and/or accelerate disease mechanisms that are slow to manifest in neurons harboring ALS point mutations. This is consistent with the fact that UBQLN2<sup>4XALS</sup> toxicity in flies was unmasked by HS, which is a well-known inducer of proteotoxicity. While caution must be taken when interpreting experiments employing the UBQLN2<sup>4XALS</sup> allele, it may serve as useful discovery tool for pathway identification in UBQLN2-associated ALS.</p><p>Among the 28 enhancer loci, we successfully mapped <italic>Rab5</italic> as the causal gene in BSC37. Rab5 silencing caused a hyperpigmented eye phenotype in flies expressing either wild-type or ALS-mutant UBQLN2 alleles, suggesting that overexpressed UBQLN2 proteins interfere with endosomal function. This finding is congruent with recent work by Senturk et al. describing a role for endogenous <italic>dUbqln</italic> in endolysosomal acidification (<xref ref-type="bibr" rid="bib73">Şentürk et al., 2019</xref>). While we attempted to map culprit genes in several other UBQLN2 enhancer loci, we were unable to identify candidate genes whose silencing fully replicated the degenerative eye phenotypes seen with the Df crosses. A plausible explanation for this is that the disruption of multiple genes is responsible for the enhancer effects of some Df lines.</p><p>Our screen identified three UBQLN2<sup>4XALS</sup> suppressors (<italic>lilli, Unc-5</italic>, and <italic>beat-1b</italic>), while a causal gene responsible for the strong phenotypic rescue by BSC19 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) could not be mapped. <italic>lilli</italic> (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>) is orthologous to mammalian <italic>AFF2/FMR2</italic> (<italic>fragile X mental retardation 2</italic>), which plays a role in transcriptional elongation (<xref ref-type="bibr" rid="bib57">Luo et al., 2012</xref>; <xref ref-type="bibr" rid="bib92">Wittwer et al., 2001</xref>). Interestingly, <italic>lilli</italic> was also identified as a phenotypic suppressor in <italic>Drosophila</italic> models for TDP-43 and C9ORF72-associated ALS (<xref ref-type="bibr" rid="bib95">Yuva-Aydemir et al., 2019</xref>; <xref ref-type="bibr" rid="bib6">Berson et al., 2019</xref>). In the C9ORF72 model, <italic>lilli</italic> mutations suppressed expression and toxicity of overexpressed poly(GR) DPRs that are produced via repeat-associated, non-ATG-dependent translation of a G4C2 hexanucleotide repeat expansion (HRE) in the <italic>C9ORF72</italic> gene (<xref ref-type="bibr" rid="bib86">Van’t Spijker and Almeida, 2023</xref>). <italic>lilli/FMR2</italic> silencing also reduced transcription of G4C2-containing repeats in iMNs and partially reversed neurite defects in patient-derived iMNs harboring the <italic>C9ORF72</italic> HRE (<xref ref-type="bibr" rid="bib95">Yuva-Aydemir et al., 2019</xref>; <xref ref-type="bibr" rid="bib6">Berson et al., 2019</xref>). UBQLN2<sup>4XALS</sup> protein levels were not affected by a <italic>lilli</italic> LOF allele in <italic>Drosophila</italic> (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), suggesting that transcriptional suppression is not responsible for phenotypic rescue in our studies. Alternatively, because <italic>lilli</italic> was also identified as a suppressor of <italic>hairless</italic> overexpression toxicity in the fly eye (<xref ref-type="bibr" rid="bib64">Müller et al., 2005</xref>), <italic>lilli</italic> LOF alleles may suppress overlapping death pathways engaged by neurodegeneration-associated proteins.</p><p>Our findings suggest that axon guidance pathways play an important role in UBQLN2-mediated toxicity in <italic>Drosophila</italic>. Unc-5 fulfills dual functions as a repulsive axon guidance factor and neuronal dependence receptor (<xref ref-type="bibr" rid="bib8">Boyer and Gupton, 2018</xref>; <xref ref-type="bibr" rid="bib43">Labrador et al., 2005</xref>; <xref ref-type="bibr" rid="bib36">Keleman and Dickson, 2001</xref>), and either or both functions could underlie phenotypic rescue of UBQLN2<sup>4XALS</sup> flies by <italic>Unc-5</italic> silencing. Knockdown of <italic>fra</italic>, which mediates chemoattractive responses to netrin, also partially rescued UBQLN2<sup>4XALS</sup>-associated eye and motor neuron phenotypes (<xref ref-type="fig" rid="fig3">Figures 3F</xref>, <xref ref-type="fig" rid="fig9">9A, C and D</xref>), raising the possibility that heterodimeric Unc-5-Fra complexes mediate toxicity initiated by UBQLN2<sup>ALS</sup> mutants. Alternatively, Unc-5 and Fra/DCC may function in partially redundant fashion to instigate toxicity in UBQLN2<sup>ALS</sup> flies.</p><p>The identification of <italic>beat-1b</italic> as a UBQLN2 modifier further supports axon pathfinding defects as a disease driver in the UBQLN2<sup>4XALS</sup> flies. Beat proteins mediate guidance of motor neuron axons through transient interactions with transmembrane Sidestep receptors whose expression pattern on muscle, muscle stem cells, and neurons constitutes a stereotypic guidance path (<xref ref-type="bibr" rid="bib22">Fambrough and Goodman, 1996</xref>; <xref ref-type="bibr" rid="bib77">Siebert et al., 2009</xref>; <xref ref-type="bibr" rid="bib1">Aberle, 2009</xref>; <xref ref-type="bibr" rid="bib4">Arzan Zarin and Labrador, 2019</xref>; <xref ref-type="bibr" rid="bib49">Li et al., 2017</xref>). Although no clear human ortholog exists, Beats exhibit weak homology to mammalian NekL3/SynCAM2/CADM2, a nectin-like molecule that mediates adhesion of myelinated axons and oligodendrocytes (<xref ref-type="bibr" rid="bib24">Frei et al., 2014</xref>; <xref ref-type="bibr" rid="bib7">Biederer et al., 2002</xref>). The potential roles of nectin-like molecules in the toxicity of UBQLN2<sup>ALS</sup> mutants in human neurons remain to be determined.</p><p>We developed UBQLN2 gene-edited iPSCs and iMNs to investigate UBQLN2 pathomechanisms at the cellular level. Endogenous UBQLN2<sup>P497H</sup> and UBQLN2<sup>4XALS</sup> exhibited wild-type localization and solubility in iPSCs in the absence of stress; however, the relative insolubility of UBQLN2<sup>4XALS</sup> seen in overexpression studies was unmasked when iPSCs were treated with the lysosomal acidification inhibitor BafA1 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). UBQLN2<sup>4XALS</sup> iMNs exhibited constitutive, p62-positive, aggregates that were distributed throughout the soma, axon, and growth cone lamellipodia, raising the possibility that such aggregates interfere with growth cone dynamics (<xref ref-type="fig" rid="fig7">Figures 7</xref> and <xref ref-type="fig" rid="fig8">8</xref>). Indeed, UBQLN2<sup>4XALS</sup> iMNs exhibited reduced neurite length, diminished neurite complexity, and reduced growth cone numbers relative to wild-type and UBQLN2<sup>P497H</sup> iMNs (<xref ref-type="fig" rid="fig7">Figures 7</xref> and <xref ref-type="fig" rid="fig9">9</xref>). While these findings imply that UBQLN2<sup>4XALS</sup> toxicity is tightly linked to its aggregation potential, it remains possible that soluble forms of UBQLN2<sup>4XALS</sup> and clinical UBQLN2<sup>ALS</sup> proteins also disrupt key cellular processes. Given genetic interactions between UBQLN2 and Rab5 in flies (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) and lysosomal enlargement seen in UBQLN2<sup>P497H</sup> and UBQLN2<sup>4XALS</sup> iPSCs (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), the endolysosomal pathway may be a particularly relevant site of soluble UBQLN2 toxicity.</p><p>Knockdown of <italic>UNC5B</italic> and <italic>DCC</italic> partially reversed the neurite complexity and growth cone morphology defects of UBQLN2<sup>4XALS</sup> iMNs, indicating that the UBQLN2<sup>4XALS</sup> toxicity mechanism is at least partially conserved between flies and humans (<xref ref-type="fig" rid="fig9">Figure 9</xref>). As in <italic>Drosophila</italic>, mammalian DCC and UNC5 family receptors have been implicated in both axon guidance and apoptosis regulation (<xref ref-type="bibr" rid="bib8">Boyer and Gupton, 2018</xref>; <xref ref-type="bibr" rid="bib55">Llambi et al., 2005</xref>; <xref ref-type="bibr" rid="bib87">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="bib3">Ahn et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Pradella et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Tang et al., 2008</xref>; <xref ref-type="bibr" rid="bib2">Ackerman et al., 1997</xref>; <xref ref-type="bibr" rid="bib47">Leonardo et al., 1997</xref>; <xref ref-type="bibr" rid="bib5">Barnault et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Tanikawa et al., 2003</xref>; <xref ref-type="bibr" rid="bib89">Williams et al., 2006</xref>; <xref ref-type="bibr" rid="bib29">Guenebeaud et al., 2010</xref>; <xref ref-type="bibr" rid="bib62">Miyamoto et al., 2010</xref>). UNC5 and DCC/Fra harbor extended cytoplasmic domains that regulate caspase activation and are themselves targets for caspase-mediated cleavage (<xref ref-type="bibr" rid="bib87">Wang et al., 2009</xref>, <xref ref-type="bibr" rid="bib54">Llambi et al., 2001</xref>; <xref ref-type="bibr" rid="bib23">Forcet et al., 2001</xref>). Engagement by netrin ligand is thought to suppress the intrinsic apoptotic potential of the UNC5 death domain (<xref ref-type="bibr" rid="bib68">Pradella et al., 2021</xref>; <xref ref-type="bibr" rid="bib87">Wang et al., 2009</xref>), while γ-secretase-mediated cleavage of UNC5C has been linked to neuronal apoptosis in Alzheimer’s disease (AD) (<xref ref-type="bibr" rid="bib13">Chen et al., 2021</xref>). The contributions of UNC5 death signaling to toxicity phenotypes in UBQLN2<sup>ALS</sup> iMNs and flies await future study.</p><p>Distal axon and synaptic defects are implicated in ALS pathogenesis and have been observed in diverse ALS disease models. For instance, reduced expression of the microtubule binding protein Stathmin 2 due to misregulation of its RNA splicing and/or polyadenylation is strongly linked to axonal growth and regeneration defects in TDP-43-associated ALS (<xref ref-type="bibr" rid="bib59">Melamed et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Klim et al., 2019</xref>). Single nucleotide polymorphisms that promote inclusion of a cryptic cassette exon in the presynaptic regulator <italic>UNC13A</italic> are a risk factor for fALS (<xref ref-type="bibr" rid="bib85">van Es et al., 2009</xref>), whereas loss of nuclear TDP-43 has been linked to UNC13A missplicing and synaptic defects in sALS (<xref ref-type="bibr" rid="bib58">Ma et al., 2022</xref>; <xref ref-type="bibr" rid="bib10">Brown et al., 2022</xref>). While <italic>UNC5B</italic> has not been implicated as an ALS gene, signaling downstream of UNC5 may contribute to axonal retraction and/or synaptic phenotypes in neurodegenerative disease. Consistent with this notion, <italic>UNC5B</italic> has been linked to neurodegeneration in the 6-OHDA model of Parkinson’s disease (<xref ref-type="bibr" rid="bib34">Jasmin et al., 2021</xref>) and <italic>UNC5C</italic> has been nominated as a risk allele in late-onset AD (<xref ref-type="bibr" rid="bib88">Wetzel-Smith et al., 2014</xref>; <xref ref-type="bibr" rid="bib40">Korvatska et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Li et al., 2018</xref>). Future studies will define the contributions of pathologic UNC5 signaling to the development and/or progression of ALS/FTD.</p><p>Finally, while findings in flies and iMNs support a conserved role for axon guidance defects in the UBQLN2 toxicity mechanism, there are several limitations to our study. First, despite careful attempts to focus on mutation-specific phenotypes, overexpression may elicit disease non-specific toxicities in flies, with subsequent impacts on genetic screens. Second, the UBQLN2<sup>4XALS</sup> mutant is not a bona fide disease allele and may elicit toxicities unrelated to those caused by clinical ALS mutations. Third, it is possible that axon guidance genes are most relevant to UBQLN2 toxicity in the context of the developing nervous system. Finally, neonatal iPSCs and their derivative iMNs, while possessing numerous strengths, are unlikely to capture age-dependent abnormalities that contribute to neurodegeneration in an intact human nervous system.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">Deficiency</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC7521</td><td align="left" valign="bottom">w[1118]; Df(2L)Exel6038, P{w[+mC]=XPU}Exel6038/CyO</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>beat-1c</italic>/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC64528</td><td align="left" valign="bottom">y(1) sc[*] v(1) sev(21); P{y[+t7.7] v[+t1.8]=TRiP.HMC05547}attP40</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>beat-1b</italic>/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC55938</td><td align="left" valign="bottom">y(1) sc[*] v(1) sev(21); P{y[+t7.7] v[+t1.8]=TRiP.HMC04226}attP40</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Rab5</italic>/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC34832</td><td align="left" valign="bottom">y(1) sc[*] v(1) sev(21); P{y[+t7.7] v[+t1.8]=TRiP.HMS00147}attP2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Luciferase/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC31603</td><td align="left" valign="bottom">y(1) v(1); P{y[+t7.7] v[+t1.8]=TRiP.JF01355}attP2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Rab5</italic>/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC30518</td><td align="left" valign="bottom">y(1) v(1); P{y[+t7.7] v[+t1.8]=TRiP.JF03335}attP2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>beat-1b</italic>/P element</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC18802</td><td align="left" valign="bottom">w[1118]; PBac{w[+mC]=WH}beat-Ib[f04746]</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Rab5/overexpression</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC43336</td><td align="left" valign="bottom">w[*]; P{w[+mC]=UAS-GFP-Rab5}3</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Unc-5</italic>/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC33756</td><td align="left" valign="bottom">y(1) sc[*] v(1) sev(21); P{y[+t7.7] v[+t1.8]=TRiP.HMS01099}attP2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Unc-5</italic>/RNAi</td><td align="left" valign="bottom">VDRC</td><td align="left" valign="bottom">VDRC8138</td><td align="left" valign="bottom">GD RNAi</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Unc-5</italic>/RNAi</td><td align="left" valign="bottom">VDRC</td><td align="left" valign="bottom">VDRC110155</td><td align="left" valign="bottom">KK RNAi</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">GFP/overexpression</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC5430</td><td align="left" valign="bottom">w[1118]; P{w[+mC]=UAS-EGFP}34/TM3, Sb(1)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Deficiency</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC24370</td><td align="left" valign="bottom">w[1118]; Df(2R)BSC346/CyO</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">mCherry/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC35787</td><td align="left" valign="bottom">y(1) sc[*] v(1) sev(21); P{y[+t7.7] v[+t1.8]=UAS-mCherry.VALIUM10}attP2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>frazzled</italic>/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC31469</td><td align="left" valign="bottom">y(1) v(1); P{y[+t7.7] v[+t1.8]=TRiP.JF01231}attP2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>frazzled</italic>/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC31664</td><td align="left" valign="bottom">y(1) v(1); P{y[+t7.7] v[+t1.8]=TRiP.JF01457}attP2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>frazzled</italic>/RNAi</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC40826</td><td align="left" valign="bottom">y(1) sc[*] v(1) sev(21); P{y[+t7.7] v[+t1.8]=TRiP.HMS01147}attP2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Deficiency (<italic>lilli</italic>)</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC9610</td><td align="left" valign="bottom">BSC180</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Deficiency (<italic>Rab5</italic>)</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC7144</td><td align="left" valign="bottom">BSC37</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Deficiency (<italic>lilli</italic>)</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC94697</td><td align="left" valign="bottom">ED4651</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Deficiency (<italic>lilli</italic>)</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC99</td><td align="left" valign="bottom">C144</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Lilli</italic> (LOF allele)</td><td align="left" valign="bottom">BDSC</td><td align="left" valign="bottom">BDSC5726</td><td align="left" valign="bottom"><italic>lilli</italic>[A17-2] cn(1) bw(1)/CyO</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Unc-5</italic> (LOF)</td><td align="left" valign="bottom">Greg Bashaw; <xref ref-type="bibr" rid="bib43">Labrador et al., 2005</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cub.2005.06.058">https://doi.org/10.1016/j.cub.2005.06.058</ext-link></td><td align="left" valign="bottom"><italic>Unc-5</italic><sup>3</sup></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom"><italic>Unc-5</italic> (LOF)</td><td align="left" valign="bottom">Greg Bashaw; <xref ref-type="bibr" rid="bib43">Labrador et al., 2005</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cub.2005.06.058">https://doi.org/10.1016/j.cub.2005.06.058</ext-link></td><td align="left" valign="bottom"><italic>Unc-5</italic><sup>8</sup></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Unc-5/overexpression</td><td align="left" valign="bottom">Greg Bashaw</td><td align="left" valign="bottom"/><td align="left" valign="bottom">HA-Unc-5 (Chr2)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Unc-5/overexpression</td><td align="left" valign="bottom">Greg Bashaw</td><td align="left" valign="bottom"/><td align="left" valign="bottom">HA-Unc-5 (Chr3)</td></tr><tr><td align="left" valign="bottom">Cell line(<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">UBQLN2<sup>WT</sup></td><td align="left" valign="bottom">WC031i-5907–6</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">UBQLN2<sup>P497H</sup></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">P497H</td><td align="left" valign="bottom">Mutation using CRISPR</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">UBQLN2<sup>2XALS</sup></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">P497H, P525S</td><td align="left" valign="bottom">Mutation using CRISPR</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">UBQLN2<sup>4XALS</sup></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">P497H, P506T, P509S, P525S</td><td align="left" valign="bottom">Mutation using CRISPR</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">UBQLN2<sup>I498X</sup></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">I498X</td><td align="left" valign="bottom">Mutation using CRISPR</td></tr><tr><td align="left" valign="bottom">Transfected construct (humani PSCs)</td><td align="left" valign="bottom">shUNC5B</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">TRCN0000442978</td><td align="left" valign="bottom">Lentiviral construct to transfect and express the shRNA in iPSCs</td></tr><tr><td align="left" valign="bottom">Transfected construct (human iPSCs)</td><td align="left" valign="bottom">shDCC</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">TRCN0000010318</td><td align="left" valign="bottom">Lentiviral construct to transfect and express the shRNA in iPSCs</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-UBQLN2 (Mouse monoclonal antibody)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat#: Ab190283</td><td align="left" valign="bottom">IF (1:1000), WB (1:10000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-UBQLN2 (Rabbit polyclonal antibody)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#: 85509</td><td align="left" valign="bottom">IF (1:500), WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-Tubulin (Mouse monoclonal antibody)</td><td align="left" valign="bottom">EMD Millipore</td><td align="left" valign="bottom">Cat#: 05–661</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-LC3A/B (Rabbit polyclonal antibody)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#: 12741S</td><td align="left" valign="bottom">IF (1:500), WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-LAMP1 (Mouse monoclonal antibody)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat#: sc-20011</td><td align="left" valign="bottom">IF (1:500), WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Rab5A (Rabbit polyclonal antibody)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#: 46449S</td><td align="left" valign="bottom">IF (1:500), WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-UBQLN1 (Rabbit polyclonal antibody)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat#: 14526</td><td align="left" valign="bottom">IF (1:500), WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Tuj1 (Mouse monoclonal antibody)</td><td align="left" valign="bottom">EMD Millipore</td><td align="left" valign="bottom">Cat#: MAB1637MI</td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-DCC (Rabbit polyclonal antibody)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat#: PA5-50946</td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-DLG<break/>(Mouse monoclonal antibody)</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">Cat#: 4F3</td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HRP- Cy3-conjugated (Goat polyclonal antibody)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat#:123-165-021</td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GAPDH-F</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GTCTCCTCTGACTTCAACAGCG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">GAPDH-R</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">ACCACCCTGTTGCTGTAGCCAA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">UNC5B-F</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">pPCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">ACTGCCGTGACTTCGACAC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">UNC5B-R</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GCCTTGCCGTCTTAAAGTTGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">DCC-F</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GACTTTACCAATGTGAGGCATCT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">DCC-R</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">qPCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GGTCCTGCTACTGCAACTTTT</named-content></td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CHIR99021</td><td align="left" valign="bottom">Tocris</td><td align="char" char="." valign="bottom">4423</td><td align="left" valign="bottom">Chemical compound, drug</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMH-1</td><td align="left" valign="bottom">Tocris</td><td align="char" char="." valign="bottom">4126</td><td align="left" valign="bottom">Chemical compound, drug</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SB431542</td><td align="left" valign="bottom">Stemgent</td><td align="char" char="." valign="bottom">04-0010</td><td align="left" valign="bottom">Chemical compound, drug</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Retinoic acid</td><td align="left" valign="bottom">Stemgent</td><td align="char" char="." valign="bottom">04-0021</td><td align="left" valign="bottom">Chemical compound, drug</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Purmorphamine</td><td align="left" valign="bottom">Stemgent</td><td align="char" char="." valign="bottom">04-0009</td><td align="left" valign="bottom">Chemical compound, drug</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Compound E</td><td align="left" valign="bottom">EMD Millipore</td><td align="char" char="." valign="bottom">565790</td><td align="left" valign="bottom">Chemical compound, drug</td></tr><tr><td align="left" valign="bottom">Software, algorithm for RNA-Seq analysis</td><td align="left" valign="bottom"><italic>Drosophila melanogaster</italic> genome (dmel-all-chromosome-r6.27, FlyBase)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/ENCODE-DCC/rna-seq-pipeline">https://github.com/ENCODE-DCC/rna-seq-pipeline</ext-link>; <xref ref-type="bibr" rid="bib21">ENCODE DCC, 2022</xref> STAR 2.7.1a</td><td align="left" valign="bottom">DESeq2,<break/>MetaScape website</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm for mass spectrometry analysis</td><td align="left" valign="bottom">MetaMorpheus software program</td><td align="left" valign="bottom"/><td align="left" valign="bottom">FlashLFQ</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title><italic>Drosophila</italic> methods</title><p>Flies were maintained with the standard cornmeal-yeast medium (Nutri-Fly BF #66-112, Genesee Scientific) supplemented with propionic acid and all crosses were performed at 22°C. For HS experiments, all crosses were performed at indicated temperatures (27°C or 29°C). Note: the UAS-Gal4 promoter contains heat-shock elements that increase transgene expression at 27°C and 29°C. Generation of isogenic UAS-UBQLN2 stocks using PhiC31 integration was previously described.</p></sec><sec id="s4-2"><title>RNA-Seq and gene expression</title><p>Total RNA was isolated from 100 male fly heads using the TRIzol reagent (Invitrogen, 15596018) following the manufacturer’s protocol and treated with TURBO Dnase (Invitrogen, AM2239). RNA samples were prepared with three biological replicates for each genotype and each temperature. Then RNA samples were sent to Novogene (Novogene Co., Ltd, Sacramento, CA, USA) for non-stranded cDNA library building and sequencing at PE150 with NovoSeq 6000. Raw reads adapters were trimmed by fastp (<xref ref-type="bibr" rid="bib12">Chen et al., 2018</xref>) and then were mapped to <italic>D. melanogaster</italic> genome (dmel-all-chromosome-r6.27, FlyBase) by STAR with the setting suggested by ENCODE project (<ext-link ext-link-type="uri" xlink:href="https://github.com/ENCODE-DCC/rna-seq-pipeline">https://github.com/ENCODE-DCC/rna-seq-pipeline</ext-link>, <xref ref-type="bibr" rid="bib19">Dobin et al., 2013</xref> STAR 2.7.1a). The number of RNA-Seq reads mapped to each transcript was summarized with featureCounts (<xref ref-type="bibr" rid="bib51">Liao et al., 2014</xref>) and differential expression was called using DESeq2 (<xref ref-type="bibr" rid="bib56">Love et al., 2014</xref>). The GO analysis was performed on MetaScape website (<xref ref-type="bibr" rid="bib98">Zhou et al., 2019</xref>).</p></sec><sec id="s4-3"><title>Fly brain immunohistochemistry</title><p>The protocol for fly brain immunohistochemistry was adapted from a previously published protocol (<xref ref-type="bibr" rid="bib96">Zhan et al., 2013</xref>). Adult fly brains were dissected using a pair of fine forceps in PBS (or 0.3% TX-100 in PBS), fixed, blocked with normal goat serum (NGS), and stained with primary antibodies at 1:500 dilution for two overnights at 4°C. After subsequent secondary antibody staining, DAPI was added for the nuclear staining. Images were acquired using a Nikon A1 confocal microscope using a 60× oil lens.</p></sec><sec id="s4-4"><title>Mass spectrometry</title><p>Fly lysates were prepared by homogenizing 100 male fly heads in 200 μl of lysis buffer containing 20 mM Tris-HCl (pH 8.0), 138 mM NaCl, 10 mM KCl, 1 mM MgCl<sub>2</sub>, 1 mM EDTA, 0.5% sodium deoxycholate w/v, and 0.1% SDS w/v (RIPA buffer w/o NP-40). Samples were centrifuged at 20,000 × <italic>g</italic> for 10 min and soluble fractions subjected to tryptic digestion and orbitrap MS using the filter aided sample preparation method (<xref ref-type="bibr" rid="bib91">Wiśniewski et al., 2009</xref>). We performed two technical replicates for each of the three biological replicates. The tryptic digest solution was desalted/concentrated using an Omix 100 μl (80 μg capacity) C18 tip and the peptides were analyzed by HPLC-ESI-MS/MS using a system consisting of a high-performance liquid chromatograph (nanoAcquity, Waters) connected to an electrospray ionization Orbitrap mass spectrometer (QE HF, Thermo Fisher Scientific). HPLC separation employed a 100×365 μm fused silica capillary micro-column packed with 20 cm of 1.7 μm diameter, 130 Å pore size, C18 beads (Waters BEH), with an emitter tip pulled to approximately 1 μm using a laser puller (Sutter Instrument). Peptides were loaded on-column at a flow rate of 400 nl/min for 30 min and then eluted over 120 min at a flow rate of 300 nl/min with a gradient of 5–35% acetonitrile, in 0.2% formic acid. Full-mass profile scans were performed in the FT orbitrap between 375 and 1500 m/z at a resolution of 120,000, followed by MS/MS HCD scans of the 10 highest intensity parent ions at 30% relative collision energy and 15,000 resolution, with a mass range starting at 100 m/z. Dynamic exclusion was enabled with a repeat count of one over a duration of 30 s. The MetaMorpheus software program was used to identify peptides and proteins in the samples (<xref ref-type="bibr" rid="bib76">Shortreed et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Solntsev et al., 2018</xref>). Protein fold changes were quantified by FlashLFQ (<xref ref-type="bibr" rid="bib61">Millikin et al., 2020</xref>; <xref ref-type="bibr" rid="bib94">Yin et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Millikin et al., 2018</xref>).</p></sec><sec id="s4-5"><title>Genetic screening</title><p>We employed the Bloomington Deficiency Kit for chromosome 2 (DK2L and DK2R) comprised of 194 different lines. All 194 lines were crossed to GMR-Gal4/CyO or homozygous GMR&gt;UBQLN2<sup>P497H</sup> or GMR&gt;UBQLN2<sup>4XALS</sup> flies at 29°C. A minimum of 30 F1 progeny containing GMR&gt;UBQLN2 either the Df chromosome or balancer chromosome were analyzed for eye morphology 1–3 days post eclosion using a blinded, 1–5 grading system, with a score of 1 representing a control (GMR-Gal4) eye; 3 corresponding to the unmodified UBQLN2<sup>4XALS</sup> phenotype at 29°C; and 5 representing severe eye degeneration featuring more than 50% necrotic tissue. We were unable to derive UBQLN2 progeny for a handful Df lines crossed to UBQLN2<sup>4XALS</sup>, suggesting lethal genetic interactions. All putative modifier Dfs were retested in secondary screens that included side-by-side crosses to GMR-Gal4, GMR&gt;UBQLN2<sup>WT</sup>, GMR&gt;UBQLN2<sup>P497H</sup>, and GMR&gt;UBQLN2<sup>4XALS</sup>. Those Dfs that were confirmed to modify GMR &gt; UBQLN2 eye phenotypes in both screens were deemed bona fide modifier Dfs. Sexually dimorphic phenotypes were also scored. <italic>Drosophila</italic> eye pictures were acquired using Leica S9 i Stereomicroscope.</p></sec><sec id="s4-6"><title><italic>Drosophila</italic> climbing assay</title><p>Climbing assay was modified from methods described previously (<xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>). Climbing ability was measured by tapping ~10 flies to the bottom of a graduated testing vial (15 cm) and taking videos over of fly movement over the course of 10 s. More than 100 flies for each genotype and each gender were used for climbing ability. Video frames at the 5 s time point were used to record the position of each fly using the multi-point plugin in ImageJ. Using the final positions of every fly and respective starting points also marked with ImageJ’s multi-point, the vertical displacement and velocity of every fly was calculated. Data showing velocity of each individual fly were graphed as scattered plots with mean climbing distance and SEM. Unpaired t-test with Welch’s correction were used for statistical analysis for different groups of flies.</p></sec><sec id="s4-7"><title><italic>Drosophila</italic> NMJ assay</title><p>NMJ assay was modified from methods described previously (<xref ref-type="bibr" rid="bib37">Kim et al., 2018</xref>). Third-instar, wandering larvae from the F1 generation were rinsed in ice-cold PBS (Lonza, 17512F) and dissected along the dorsal midline. All tissues except the brain and nerves were removed to expose the muscles and NMJs. The dissected larval pelt was fixed in 4% paraformaldehyde for 20 min at room temperature. The larval pelts were given a wash with PBS followed by blocking with 5% NGS in 0.1% PBST (0.1% TX-100 in PBS). Following blocking, the larval pelts were probed with primary antibodies overnight at 4°C. They were then washed several times with 0.1% PBST followed by incubation with secondary antibodies for 2 hr at room temperature, subsequently followed by washes with 0.1% PBST. Larvae were then mounted onto slides using Prolong Gold mounting media. Confocal images were acquired using Zeiss LSM 710 confocal microscope and a 60× oil objective was used to image the NMJs. Both primary and secondary antibody solutions were prepared in 5% NGS in 0.1% PBST. For primary antibodies, the following dilutions were used: 1:100 Cy3-conjugated goat anti-HRP (Jackson ImmunoResearch, 123-165-021); 1:100 mouse anti-DLG 4F3 (DSHB). For secondary antibodies, the following antibody dilutions were used: 1:250 Alexa Fluor 647-conjugated phalloidin (Invitrogen, A22287); 1:500 goat anti-mouse Alexa Fluor 488 (Invitrogen, A-11029). For the analyses, NMJs innervating muscle 4 on segments A2-A3 were imaged and analyzed for synaptic bouton quantification. Mature boutons are defined as boutons that are included in a chain of two or more boutons. Satellite boutons are defined as a single bouton that is not included in a chain of boutons, and instead, sprout off of a mature bouton or branch. The groups were compared using unpaired Student’s t-test on GraphPad Prism software. p-Value less than 0.05 was considered statistically significant.</p></sec><sec id="s4-8"><title><italic>Drosophila</italic> longevity assays</title><p>Longevity assay was modified from methods described previously (<xref ref-type="bibr" rid="bib96">Zhan et al., 2013</xref>). For survival analysis, flies were aged at 27°C with no more than 15 flies per vial. Total more than 100 flies were used for each genotype. Vials were changed on a 2- to 3-day cycle. Death events were scored on a daily basis. Rescue in longevity was defined as greater than 5% increase in median lifespan in addition to the statistical threshold according to the Log-rank (Mantel-Cox) test, p&lt;0.05. In the survival graphs shown, each set of experiments was done in the same time period with the corresponding control subjects in order to control longevity variation caused by environmental factors. Both genders were used in the survival assay unless otherwise specified.</p></sec><sec id="s4-9"><title>iPSC culture and motor neuron differentiation</title><p>A normal iPSC line (WC031i-5907-6, fibroblasts from neonatal male) was obtained from WiCell Research Institute (<xref ref-type="bibr" rid="bib94">Yin et al., 2019</xref>). Into this line we introduced the following mutations using CRISPR/CAS9: P497H, 2XALS (P497H, P525S), 4XALS (P497H, P506T, P509S, P525S), and I498X, which harbors a 1 nt deletion in codon 497 that leads to frameshift and translation termination at codon 498. UBQLN2<sup>P497H</sup>, UBQLN2<sup>2XALS</sup>, and UBQLN2<sup>4XALS</sup> lines were sequenced for the top five ranking off-target cleavages (none were found) and confirmed for expression of pluripotency markers. All iPSCs have normal karyotypes, express stem cell markers, exhibit pluripotency (as assessed by capacity to differentiate into three germ layers), and were mycoplasma negative (<xref ref-type="bibr" rid="bib94">Yin et al., 2019</xref>). STR analysis defines profile for each line, confirms clonality and purity to 95–98% confidence. Fifteen loci were tested, all matched appropriate source fibroblasts. iPSCs were cultured with mTeSR1 (Stemcell Technologies) on Matrigel (Corning). iPSCs on Matrigel were passaged with 0.5 mM EDTA. iPSC colonies were passaged every 4–7 days at a 1:3 to 1:6 split ratio.</p><p>Differentiation of iPSCs into iMNs was carried out as previously described (<xref ref-type="bibr" rid="bib20">Du et al., 2015</xref>). In brief, iPSCs were dissociated and placed in Matrigel-coated plates. On the following day, the iPSC medium was replaced with a chemically defined neural differentiation medium, including DMEM/F12, Neurobasal medium at 1:1, 0.5×N2, 0.5×B27, and 1×Glutamax (all are from Invitrogen). CHIR99021 (3 μM, Torcris), 2 μM DMH-1 (Torcris), and 2 μM SB431542 (Stemgent) were added in the medium. The culture medium was changed every other day. Human iPSCs maintained under this condition for 7 days were induced into neuroepithelial progenitors (NEP). The NEP cells were then dissociated with dispase (1 mg/ml) and split at 1:6 with neural differentiation medium described above. Retinoic acid (RA, 0.1 μM, Stemgent) and 0.5 μM purmorphamine (Stemgent) were added in combination with 1 μM CHIR99021, 2 μM DMH-1, and 2 μM SB431542. The medium was changed every other day. NEP cells maintained under this condition for 7 days differentiated into OLIG2+ motor neuron progenitors (MNPs). To induce motor neuron differentiation, OLIG2+ MNPs were dissociated with EDTA (0.5 mM) and cultured in suspension in the above neural differentiation medium with 0.1 μM RA and 0.1 μM purmorphamine. The medium was changed every other day. OLIG2+ MNPs under this condition for 6 days differentiated into HB9+ NMPs. The HB9+ NMPs were then dissociated with Accutase (Invitrogen) into single cells and plated on Matrigel-coated plates. The HB9+ NMPs were cultured with 0.1 μM RA, 0.1 μM purmorphamine, and 0.1 μM Compound E (Millipore) for 6 days to mature into CHAT+ iMNs.</p></sec><sec id="s4-10"><title>Microscopy</title><p>For immunostaining, iPSCs and iMNs were fixed with 4% paraformaldehyde in PBS, permeabilized with 0.2% PBST, blocked with 2% BSA, and stained with primary antibodies for overnight at 4°C and then stained with α-rabbit-Alex-488 and α-mouse-Alexa-594-conjugated secondary antibodies. Images were acquired using a Nikon A1 confocal microscope using either a 20× lens or a 60× oil lens. For Lysotracker assays, iPSCs were incubated with 70 nM LysoTracker Red DND-99 (L7528, Invitrogen) for 1 hr at 37°C in culture medium. Live microscopy of lysosomes was performed using a Nikon A1 confocal microscope with a heated chamber and an objective to maintain the cells at 37°C using a 60× oil lens.</p></sec><sec id="s4-11"><title>Immunoblotting</title><p>Fly lysates were prepared by homogenizing 10 fly heads in 50 μl of RIPA lysis buffer. The soluble fraction was taken after centrifugation at 21,000 × <italic>g</italic> in a microcentrifuge for 10 min iPSC extract were prepared using in lysis buffer containing 20 mM Tris-HCl (pH 8.0), 138 mM NaCl, 10 mM KCl, 1 mM MgCl<sub>2</sub>, 1 mM EDTA, and 1% Triton-X 100 vol/vol (TX buffer). All lysis buffers were supplemented with protease inhibitor cocktail (Sigma, P8340), 10 mM NaF, and 1 mM DTT. Following centrifugation at 21,000 × <italic>g</italic> for 15 min, the insoluble pellet was washed twice with PBS, then suspended and boiled in Laemmli buffer. For immunoblotting, samples were separated by SDS-PAGE and transferred to PVDF membranes and immunoblotted with primary antibodies and LI-COR IRDye secondary antibodies (IRDye 800CW goat anti-rabbit and IRDye 680RD goat anti-mouse) as described. Signals were acquired using Odyssey bio-systems (LI-COR Biosciences). Immunoblotting results were analyzed and organized with ImageStudio Lite software (LI-COR).</p></sec><sec id="s4-12"><title>Limited proteolysis</title><p>iPSCs were lysed in buffer containing 20 mM Tris-HCl (pH 8.0), 138 mM NaCl, 10 mM KCl, 1 mM MgCl<sub>2</sub>, 1 mM EDTA, and 0.2% NP-40 vol/vol. A total of 20 μg of each protein lysate in 10 μl was digested with increasing amounts of chymotrypsin (0.05–0. 2 μg/ml, final volume, Sigma) for 5 min at room temperature. Digestion was terminated by addition of Laemmli loading dye and boiling at 95°C for 5 min. The digested proteins were analyzed by Western blotting with anti-UBQLN2 antibodies.</p></sec><sec id="s4-13"><title>Sholl analysis</title><p>Sholl analysis was done by determining the number of neurite branches at various radial distances from the cell body. The rate at which branching decreases as a function of distance is the Sholl regression coefficient, or Sholl decay. Digitizing individual neurite branching patterns, or tracing, was performed using the Simple Neurite Tracer (SNT) plugin in ImageJ. Semi-automatic tracing of β-tubulin staining in iMNs was carried out blinded on individual neurons. SNT’s Python application programming interface was implemented to measure the number of branch points and their respective radial distances. Other morphological descriptors including neurite length, branching number, and primary neurite number were measured in a similar way and graphed as scatter plots in GraphPad. Using the Python programming language, linear regression was fitted to the semi-log plots of the total branch points for every 1 μm radial distances.</p><p>There are a variety of ways to perform curve fitting for Sholl analysis, including linear mixed models. However, mixed models are necessary for samples with extensive clustering or heterogenity (<xref ref-type="bibr" rid="bib90">Wilson et al., 2017</xref>). Since each sample was differentiated, immunostained, and imaged simultaneously and in the same way, a simple linear regression model was appropriate. To ensure each linear fit was an accurate approximation of branch point distribution, only linear fits with a high Pearson’s correlation (R<sup>2</sup>&gt;0.8) were used to calculate the Sholl coefficient (<xref ref-type="disp-formula" rid="equ1">Equation 1</xref>). Individual neuron Sholl decay was graphed as scatter plots using GraphPad, where each neuron was one data point. Since neurons with a low Pearson’s correlation were excluded in this analysis, all neurons of a given genotype were combined into one Sholl plot, in an additional, more inclusive analysis. This was accomplished by plotting the average number of branch points at 1 μm intervals among all neurons of a given genotype. Due to high variation of branching within each sample, only branch points that fell within the 10–90 percentile were linearly fitted to yield the overall Sholl decay for each genotype.<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:msup><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mo>-</mml:mo><mml:mi>k</mml:mi><mml:mi>r</mml:mi><mml:mo>+</mml:mo><mml:mi>m</mml:mi></mml:math></disp-formula><disp-formula id="equ2"><mml:math id="m2"><mml:mi>N</mml:mi><mml:mo>=</mml:mo><mml:mo>#</mml:mo><mml:mi> </mml:mi><mml:mi>b</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi> </mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>s</mml:mi><mml:mi> </mml:mi><mml:mo>(</mml:mo><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mo>)</mml:mo></mml:math></disp-formula><disp-formula id="equ3"><mml:math id="m3"><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mi> </mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi> </mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi> </mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi> </mml:mi><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi></mml:math></disp-formula><disp-formula id="equ4"><mml:math id="m4"><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mi> </mml:mi><mml:mi>S</mml:mi><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>l</mml:mi><mml:mi> </mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi> </mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>e</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi></mml:math></disp-formula><disp-formula id="equ5"><mml:math id="m5"><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mi> </mml:mi><mml:mi> </mml:mi><mml:mi>y</mml:mi><mml:mi> </mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>c</mml:mi><mml:mi>e</mml:mi><mml:mi>p</mml:mi><mml:mi>t</mml:mi><mml:mi> </mml:mi><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi> </mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi> </mml:mi><mml:mi>f</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mi> </mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:math></disp-formula></p></sec><sec id="s4-14"><title>Growth cone analysis</title><p>Neurite terminals to the cell body were classified as growth cones (filopodial and lamellipodial ends, <xref ref-type="fig" rid="fig9">Figure 9B</xref>, arrows in UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup>) or blunt ends (<xref ref-type="fig" rid="fig9">Figure 9B</xref> UBQLN2<sup>4XALS</sup>). The percent of neurite terminals classified as growth cones was measured for individual neurons.</p></sec><sec id="s4-15"><title>Pearson’s correlation coefficients for colocalization analysis</title><p>For the fluorescence quantification of colocalization images, neuronal cell body regions were extracted from each image using ImageJ/Fiji’s selection tool. Thresholding of every region removed background signals. Pearson’s colocalization coefficients of each cell body region were determined using ImageJ/Fiji’s colocalization package. Pearson’s coefficients were plotted as a bar graph to compare the colocalization (rho = 1) or exclusion (rho = –1) of UBQLN2 with LC3, Rab5, LAMP1, or P62. Ten sight fields for each group were analyzed.</p></sec><sec id="s4-16"><title>Statistical processing</title><p>Statistical analysis information including individual replicates and biological replicates number, mean or median, and error bars are explained in the figure legends. The statistical tests and resulting p-values are shown in the figure legends and/or figure panels.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Software, Formal analysis, Validation, Visualization</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Validation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Validation, Visualization</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Visualization</p></fn><fn fn-type="con" id="con7"><p>Validation, Visualization</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Validation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con10"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-84382-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The RNA sequencing raw dataset has been deposited to Dryad and is accessible at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.tdz08kq39">https://doi.org/10.5061/dryad.tdz08kq39</ext-link>. All data generated or analyzed during this study are included in the manuscript.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Tibbetts</surname><given-names>RS</given-names></name><name><surname>Jia</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Transcriptomic analysis of UBQLN2-ALS <italic>Drosophila</italic></data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.tdz08kq39</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors would like to thank Lance A Rodenkirch (UW-Madison) for imaging assistance and Dr. Ludo Van Den Bosch, Dr. Katarina Ditlau, and Lisha Ye (University of Lueven) for helpful advice. This work was supported by grants from the National Institutes of Health (1RF1AG069483-01A1 to RST); National Institutes of Health/NCI (1R21 NS101661-01-A1 to RST); ALS Association (Proteostatic regulation by Ubiquilins in ALS to RST); National Institute on Aging (R21 AG065896-01A1 to SHK).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aberle</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Searching for guidance cues: follow the sidestep TRAIL</article-title><source>Fly</source><volume>3</volume><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.4161/fly.9790</pub-id><pub-id pub-id-type="pmid">19786838</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackerman</surname><given-names>SL</given-names></name><name><surname>Kozak</surname><given-names>LP</given-names></name><name><surname>Przyborski</surname><given-names>SA</given-names></name><name><surname>Rund</surname><given-names>LA</given-names></name><name><surname>Boyer</surname><given-names>BB</given-names></name><name><surname>Knowles</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein</article-title><source>Nature</source><volume>386</volume><fpage>838</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1038/386838a0</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>EH</given-names></name><name><surname>Kang</surname><given-names>SS</given-names></name><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Netrin1 deficiency activates MST1 via UNC5B receptor, promoting dopaminergic apoptosis in Parkinson’s disease</article-title><source>PNAS</source><volume>117</volume><fpage>24503</fpage><lpage>24513</lpage><pub-id pub-id-type="doi">10.1073/pnas.2004087117</pub-id><pub-id pub-id-type="pmid">32929029</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arzan Zarin</surname><given-names>A</given-names></name><name><surname>Labrador</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Motor axon guidance in <italic>Drosophila</italic></article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>85</volume><fpage>36</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.11.013</pub-id><pub-id pub-id-type="pmid">29155221</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnault</surname><given-names>R</given-names></name><name><surname>Lahlali</surname><given-names>T</given-names></name><name><surname>Plissonnier</surname><given-names>M-L</given-names></name><name><surname>Romero-López</surname><given-names>C</given-names></name><name><surname>Laverdure</surname><given-names>N</given-names></name><name><surname>Ducarouge</surname><given-names>B</given-names></name><name><surname>Rivoire</surname><given-names>M</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name><name><surname>Zoulim</surname><given-names>F</given-names></name><name><surname>Parent</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hepatocellular carcinoma-associated depletion of the netrin-1 receptor Uncoordinated Phenotype-5A (UNC5A) skews the hepatic unfolded protein response towards prosurvival outcomes</article-title><source>Biochemical and Biophysical Research Communications</source><volume>495</volume><fpage>2425</fpage><lpage>2431</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.12.129</pub-id><pub-id pub-id-type="pmid">29277614</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berson</surname><given-names>A</given-names></name><name><surname>Goodman</surname><given-names>LD</given-names></name><name><surname>Sartoris</surname><given-names>AN</given-names></name><name><surname>Otte</surname><given-names>CG</given-names></name><name><surname>Aykit</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>VM-Y</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Bonini</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Drosophila</italic> ref1/ALYREF regulates transcription and toxicity associated with ALS/FTD disease etiologies</article-title><source>Acta Neuropathologica Communications</source><volume>7</volume><elocation-id>65</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-019-0710-x</pub-id><pub-id pub-id-type="pmid">31036086</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biederer</surname><given-names>T</given-names></name><name><surname>Sara</surname><given-names>Y</given-names></name><name><surname>Mozhayeva</surname><given-names>M</given-names></name><name><surname>Atasoy</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Kavalali</surname><given-names>ET</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Syncam, a synaptic adhesion molecule that drives synapse assembly</article-title><source>Science</source><volume>297</volume><fpage>1525</fpage><lpage>1531</lpage><pub-id pub-id-type="doi">10.1126/science.1072356</pub-id><pub-id pub-id-type="pmid">12202822</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname><given-names>NP</given-names></name><name><surname>Gupton</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Revisiting netrin-1: one who guides (axons)</article-title><source>Frontiers in Cellular Neuroscience</source><volume>12</volume><elocation-id>221</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2018.00221</pub-id><pub-id pub-id-type="pmid">30108487</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brettschneider</surname><given-names>J</given-names></name><name><surname>Van Deerlin</surname><given-names>VM</given-names></name><name><surname>Robinson</surname><given-names>JL</given-names></name><name><surname>Kwong</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>EB</given-names></name><name><surname>Ali</surname><given-names>YO</given-names></name><name><surname>Safren</surname><given-names>N</given-names></name><name><surname>Monteiro</surname><given-names>MJ</given-names></name><name><surname>Toledo</surname><given-names>JB</given-names></name><name><surname>Elman</surname><given-names>L</given-names></name><name><surname>McCluskey</surname><given-names>L</given-names></name><name><surname>Irwin</surname><given-names>DJ</given-names></name><name><surname>Grossman</surname><given-names>M</given-names></name><name><surname>Molina-Porcel</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>VM-Y</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9orf72 hexanucleotide expansion</article-title><source>Acta Neuropathologica</source><volume>123</volume><fpage>825</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1007/s00401-012-0970-z</pub-id><pub-id pub-id-type="pmid">22426854</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A-L</given-names></name><name><surname>Wilkins</surname><given-names>OG</given-names></name><name><surname>Keuss</surname><given-names>MJ</given-names></name><name><surname>Hill</surname><given-names>SE</given-names></name><name><surname>Zanovello</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>WC</given-names></name><name><surname>Bampton</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>FCY</given-names></name><name><surname>Masino</surname><given-names>L</given-names></name><name><surname>Qi</surname><given-names>YA</given-names></name><name><surname>Bryce-Smith</surname><given-names>S</given-names></name><name><surname>Gatt</surname><given-names>A</given-names></name><name><surname>Hallegger</surname><given-names>M</given-names></name><name><surname>Fagegaltier</surname><given-names>D</given-names></name><name><surname>Phatnani</surname><given-names>H</given-names></name><collab>NYGC ALS Consortium</collab><name><surname>Newcombe</surname><given-names>J</given-names></name><name><surname>Gustavsson</surname><given-names>EK</given-names></name><name><surname>Seddighi</surname><given-names>S</given-names></name><name><surname>Reyes</surname><given-names>JF</given-names></name><name><surname>Coon</surname><given-names>SL</given-names></name><name><surname>Ramos</surname><given-names>D</given-names></name><name><surname>Schiavo</surname><given-names>G</given-names></name><name><surname>Fisher</surname><given-names>EMC</given-names></name><name><surname>Raj</surname><given-names>T</given-names></name><name><surname>Secrier</surname><given-names>M</given-names></name><name><surname>Lashley</surname><given-names>T</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name><name><surname>Buratti</surname><given-names>E</given-names></name><name><surname>Humphrey</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>ME</given-names></name><name><surname>Fratta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Tdp-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A</article-title><source>Nature</source><volume>603</volume><fpage>131</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04436-3</pub-id><pub-id pub-id-type="pmid">35197628</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>SS-Y</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>M-W</given-names></name><name><surname>Wilk</surname><given-names>R</given-names></name><name><surname>Killeen</surname><given-names>MT</given-names></name><name><surname>Hedgecock</surname><given-names>EM</given-names></name><name><surname>Culotti</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Unc-40, a <italic>C. elegans</italic> homolog of DCC (deleted in colorectal cancer), is required in motile cells responding to UNC-6 netrin cues</article-title><source>Cell</source><volume>87</volume><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81337-9</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fastp: an ultra-fast all-in-one FASTQ preprocessor</article-title><source>Bioinformatics</source><volume>34</volume><fpage>i884</fpage><lpage>i890</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty560</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Kang</surname><given-names>SS</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Ahn</surname><given-names>EH</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Sandoval</surname><given-names>IM</given-names></name><name><surname>Manfredsson</surname><given-names>FP</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Netrin-1 receptor UNC5C cleavage by active δ-secretase enhances neurodegeneration, promoting alzheimer’s disease pathologies</article-title><source>Science Advances</source><volume>7</volume><elocation-id>4499</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abe4499</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>C-Y</given-names></name><name><surname>Berson</surname><given-names>A</given-names></name><name><surname>Kennerdell</surname><given-names>JR</given-names></name><name><surname>Sartoris</surname><given-names>A</given-names></name><name><surname>Unger</surname><given-names>T</given-names></name><name><surname>Porta</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>H-J</given-names></name><name><surname>Smith</surname><given-names>ER</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name><name><surname>Van Deerlin</surname><given-names>V</given-names></name><name><surname>Lee</surname><given-names>VM-Y</given-names></name><name><surname>Chen-Plotkin</surname><given-names>A</given-names></name><name><surname>Bonini</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4406</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06543-0</pub-id><pub-id pub-id-type="pmid">30353006</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dao</surname><given-names>TP</given-names></name><name><surname>Kolaitis</surname><given-names>R-M</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>O’Donovan</surname><given-names>K</given-names></name><name><surname>Martyniak</surname><given-names>B</given-names></name><name><surname>Colicino</surname><given-names>E</given-names></name><name><surname>Hehnly</surname><given-names>H</given-names></name><name><surname>Taylor</surname><given-names>JP</given-names></name><name><surname>Castañeda</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions</article-title><source>Molecular Cell</source><volume>69</volume><fpage>965</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.02.004</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daoud</surname><given-names>H</given-names></name><name><surname>Suhail</surname><given-names>H</given-names></name><name><surname>Szuto</surname><given-names>A</given-names></name><name><surname>Camu</surname><given-names>W</given-names></name><name><surname>Salachas</surname><given-names>F</given-names></name><name><surname>Meininger</surname><given-names>V</given-names></name><name><surname>Bouchard</surname><given-names>J-P</given-names></name><name><surname>Dupré</surname><given-names>N</given-names></name><name><surname>Dion</surname><given-names>PA</given-names></name><name><surname>Rouleau</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Ubqln2 mutations are rare in French and French-Canadian amyotrophic lateral sclerosis</article-title><source>Neurobiology of Aging</source><volume>33</volume><elocation-id>2230</elocation-id><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.03.015</pub-id><pub-id pub-id-type="pmid">22560112</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>S</given-names></name><name><surname>Cavallo</surname><given-names>JA</given-names></name><name><surname>Rios</surname><given-names>CD</given-names></name><name><surname>Dworak</surname><given-names>HA</given-names></name><name><surname>Sink</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Target recognition and synaptogenesis by motor axons: responses to the sidestep protein</article-title><source>International Journal of Developmental Neuroscience</source><volume>23</volume><fpage>397</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.ijdevneu.2004.10.002</pub-id><pub-id pub-id-type="pmid">15927764</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H-X</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Hong</surname><given-names>S-T</given-names></name><name><surname>Boycott</surname><given-names>KM</given-names></name><name><surname>Gorrie</surname><given-names>GH</given-names></name><name><surname>Siddique</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Fecto</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhai</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Hirano</surname><given-names>M</given-names></name><name><surname>Rampersaud</surname><given-names>E</given-names></name><name><surname>Jansen</surname><given-names>GH</given-names></name><name><surname>Donkervoort</surname><given-names>S</given-names></name><name><surname>Bigio</surname><given-names>EH</given-names></name><name><surname>Brooks</surname><given-names>BR</given-names></name><name><surname>Ajroud</surname><given-names>K</given-names></name><name><surname>Sufit</surname><given-names>RL</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Mugnaini</surname><given-names>E</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name><name><surname>Siddique</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia</article-title><source>Nature</source><volume>477</volume><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/nature10353</pub-id><pub-id pub-id-type="pmid">21857683</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Star: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Z-W</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Qian</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>C-L</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>S-C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6626</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7626</pub-id><pub-id pub-id-type="pmid">25806427</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="software"><person-group person-group-type="author"><collab>ENCODE DCC</collab></person-group><year iso-8601-date="2022">2022</year><data-title>Rna-Seq-pipeline</data-title><version designator="53d8c96">53d8c96</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/ENCODE-DCC/rna-seq-pipeline">https://github.com/ENCODE-DCC/rna-seq-pipeline</ext-link></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fambrough</surname><given-names>D</given-names></name><name><surname>Goodman</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The <italic>Drosophila</italic> beaten path gene encodes a novel secreted protein that regulates defasciculation at motor axon choice points</article-title><source>Cell</source><volume>87</volume><fpage>1049</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81799-7</pub-id><pub-id pub-id-type="pmid">8978609</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forcet</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Granger</surname><given-names>L</given-names></name><name><surname>Corset</surname><given-names>V</given-names></name><name><surname>Shin</surname><given-names>H</given-names></name><name><surname>Bredesen</surname><given-names>DE</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation</article-title><source>PNAS</source><volume>98</volume><fpage>3416</fpage><lpage>3421</lpage><pub-id pub-id-type="doi">10.1073/pnas.051378298</pub-id><pub-id pub-id-type="pmid">11248093</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frei</surname><given-names>JA</given-names></name><name><surname>Andermatt</surname><given-names>I</given-names></name><name><surname>Gesemann</surname><given-names>M</given-names></name><name><surname>Stoeckli</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The SynCAM synaptic cell adhesion molecules are involved in sensory axon pathfinding by regulating axon-axon contacts</article-title><source>Journal of Cell Science</source><volume>127</volume><fpage>5288</fpage><lpage>5302</lpage><pub-id pub-id-type="doi">10.1242/jcs.157032</pub-id><pub-id pub-id-type="pmid">25335893</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fry</surname><given-names>MY</given-names></name><name><surname>Saladi</surname><given-names>SM</given-names></name><name><surname>Clemons</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The STI1-domain is a flexible alpha-helical fold with a hydrophobic groove</article-title><source>Protein Science</source><volume>30</volume><fpage>882</fpage><lpage>898</lpage><pub-id pub-id-type="doi">10.1002/pro.4049</pub-id><pub-id pub-id-type="pmid">33620121</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gellera</surname><given-names>C</given-names></name><name><surname>Tiloca</surname><given-names>C</given-names></name><name><surname>Del Bo</surname><given-names>R</given-names></name><name><surname>Corrado</surname><given-names>L</given-names></name><name><surname>Pensato</surname><given-names>V</given-names></name><name><surname>Agostini</surname><given-names>J</given-names></name><name><surname>Cereda</surname><given-names>C</given-names></name><name><surname>Ratti</surname><given-names>A</given-names></name><name><surname>Castellotti</surname><given-names>B</given-names></name><name><surname>Corti</surname><given-names>S</given-names></name><name><surname>Bagarotti</surname><given-names>A</given-names></name><name><surname>Cagnin</surname><given-names>A</given-names></name><name><surname>Milani</surname><given-names>P</given-names></name><name><surname>Gabelli</surname><given-names>C</given-names></name><name><surname>Riboldi</surname><given-names>G</given-names></name><name><surname>Mazzini</surname><given-names>L</given-names></name><name><surname>Sorarù</surname><given-names>G</given-names></name><name><surname>D’Alfonso</surname><given-names>S</given-names></name><name><surname>Taroni</surname><given-names>F</given-names></name><name><surname>Comi</surname><given-names>GP</given-names></name><name><surname>Ticozzi</surname><given-names>N</given-names></name><name><surname>Silani</surname><given-names>V</given-names></name><collab>SLAGEN Consortium</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Ubiquilin 2 mutations in italian patients with amyotrophic lateral sclerosis and frontotemporal dementia</article-title><source>Journal of Neurology, Neurosurgery, and Psychiatry</source><volume>84</volume><fpage>183</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2012-303433</pub-id><pub-id pub-id-type="pmid">23138764</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gkazi</surname><given-names>SA</given-names></name><name><surname>Troakes</surname><given-names>C</given-names></name><name><surname>Topp</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name><name><surname>Vance</surname><given-names>CA</given-names></name><name><surname>Sreedharan</surname><given-names>J</given-names></name><name><surname>Al-Chalabi</surname><given-names>A</given-names></name><name><surname>Kirby</surname><given-names>J</given-names></name><name><surname>Shaw</surname><given-names>PJ</given-names></name><name><surname>Al-Sarraj</surname><given-names>S</given-names></name><name><surname>King</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>BN</given-names></name><name><surname>Shaw</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia</article-title><source>Neurobiology of Aging</source><volume>73</volume><elocation-id>229</elocation-id><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.08.015</pub-id><pub-id pub-id-type="pmid">30348461</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorrie</surname><given-names>GH</given-names></name><name><surname>Fecto</surname><given-names>F</given-names></name><name><surname>Radzicki</surname><given-names>D</given-names></name><name><surname>Weiss</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Zhai</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Arrat</surname><given-names>H</given-names></name><name><surname>Bigio</surname><given-names>EH</given-names></name><name><surname>Disterhoft</surname><given-names>JF</given-names></name><name><surname>Martina</surname><given-names>M</given-names></name><name><surname>Mugnaini</surname><given-names>E</given-names></name><name><surname>Siddique</surname><given-names>T</given-names></name><name><surname>Deng</surname><given-names>H-X</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2</article-title><source>PNAS</source><volume>111</volume><fpage>14524</fpage><lpage>14529</lpage><pub-id pub-id-type="doi">10.1073/pnas.1405741111</pub-id><pub-id pub-id-type="pmid">25246588</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guenebeaud</surname><given-names>C</given-names></name><name><surname>Goldschneider</surname><given-names>D</given-names></name><name><surname>Castets</surname><given-names>M</given-names></name><name><surname>Guix</surname><given-names>C</given-names></name><name><surname>Chazot</surname><given-names>G</given-names></name><name><surname>Delloye-Bourgeois</surname><given-names>C</given-names></name><name><surname>Eisenberg-Lerner</surname><given-names>A</given-names></name><name><surname>Shohat</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Laudet</surname><given-names>V</given-names></name><name><surname>Kimchi</surname><given-names>A</given-names></name><name><surname>Bernet</surname><given-names>A</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The dependence receptor UNC5H2/B triggers apoptosis via PP2A-mediated dephosphorylation of DAP kinase</article-title><source>Molecular Cell</source><volume>40</volume><fpage>863</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.11.021</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname><given-names>KL</given-names></name><name><surname>Contreras-Moreira</surname><given-names>B</given-names></name><name><surname>De Silva</surname><given-names>N</given-names></name><name><surname>Maslen</surname><given-names>G</given-names></name><name><surname>Akanni</surname><given-names>W</given-names></name><name><surname>Allen</surname><given-names>J</given-names></name><name><surname>Alvarez-Jarreta</surname><given-names>J</given-names></name><name><surname>Barba</surname><given-names>M</given-names></name><name><surname>Bolser</surname><given-names>DM</given-names></name><name><surname>Cambell</surname><given-names>L</given-names></name><name><surname>Carbajo</surname><given-names>M</given-names></name><name><surname>Chakiachvili</surname><given-names>M</given-names></name><name><surname>Christensen</surname><given-names>M</given-names></name><name><surname>Cummins</surname><given-names>C</given-names></name><name><surname>Cuzick</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>P</given-names></name><name><surname>Fexova</surname><given-names>S</given-names></name><name><surname>Gall</surname><given-names>A</given-names></name><name><surname>George</surname><given-names>N</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Hammond-Kosack</surname><given-names>KE</given-names></name><name><surname>Haskell</surname><given-names>E</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Jaiswal</surname><given-names>P</given-names></name><name><surname>Janacek</surname><given-names>SH</given-names></name><name><surname>Kersey</surname><given-names>PJ</given-names></name><name><surname>Langridge</surname><given-names>N</given-names></name><name><surname>Maheswari</surname><given-names>U</given-names></name><name><surname>Maurel</surname><given-names>T</given-names></name><name><surname>McDowall</surname><given-names>MD</given-names></name><name><surname>Moore</surname><given-names>B</given-names></name><name><surname>Muffato</surname><given-names>M</given-names></name><name><surname>Naamati</surname><given-names>G</given-names></name><name><surname>Naithani</surname><given-names>S</given-names></name><name><surname>Olson</surname><given-names>A</given-names></name><name><surname>Papatheodorou</surname><given-names>I</given-names></name><name><surname>Patricio</surname><given-names>M</given-names></name><name><surname>Paulini</surname><given-names>M</given-names></name><name><surname>Pedro</surname><given-names>H</given-names></name><name><surname>Perry</surname><given-names>E</given-names></name><name><surname>Preece</surname><given-names>J</given-names></name><name><surname>Rosello</surname><given-names>M</given-names></name><name><surname>Russell</surname><given-names>M</given-names></name><name><surname>Sitnik</surname><given-names>V</given-names></name><name><surname>Staines</surname><given-names>DM</given-names></name><name><surname>Stein</surname><given-names>J</given-names></name><name><surname>Tello-Ruiz</surname><given-names>MK</given-names></name><name><surname>Trevanion</surname><given-names>SJ</given-names></name><name><surname>Urban</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Ware</surname><given-names>D</given-names></name><name><surname>Williams</surname><given-names>G</given-names></name><name><surname>Yates</surname><given-names>AD</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ensembl genomes 2020-enabling non-vertebrate genomic research</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>D689</fpage><lpage>D695</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz890</pub-id><pub-id pub-id-type="pmid">31598706</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>F</given-names></name><name><surname>Spannl</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>C</given-names></name><name><surname>Hyman</surname><given-names>AA</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Zerial</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rab5 and alsin regulate stress-activated cytoprotective signaling on mitochondria</article-title><source>eLife</source><volume>7</volume><elocation-id>e32282</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.32282</pub-id><pub-id pub-id-type="pmid">29469808</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Xia</surname><given-names>XG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Increased ubqln2 expression causes neuron death in transgenic rats</article-title><source>Journal of Neurochemistry</source><volume>139</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1111/jnc.13748</pub-id><pub-id pub-id-type="pmid">27456931</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itakura</surname><given-names>E</given-names></name><name><surname>Zavodszky</surname><given-names>E</given-names></name><name><surname>Shao</surname><given-names>S</given-names></name><name><surname>Wohlever</surname><given-names>ML</given-names></name><name><surname>Keenan</surname><given-names>RJ</given-names></name><name><surname>Hegde</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ubiquilins chaperone and triage mitochondrial membrane proteins for degradation</article-title><source>Molecular Cell</source><volume>63</volume><fpage>21</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.05.020</pub-id><pub-id pub-id-type="pmid">27345149</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jasmin</surname><given-names>M</given-names></name><name><surname>Ahn</surname><given-names>EH</given-names></name><name><surname>Voutilainen</surname><given-names>MH</given-names></name><name><surname>Fombonne</surname><given-names>J</given-names></name><name><surname>Guix</surname><given-names>C</given-names></name><name><surname>Viljakainen</surname><given-names>T</given-names></name><name><surname>Kang</surname><given-names>SS</given-names></name><name><surname>Yu</surname><given-names>L-Y</given-names></name><name><surname>Saarma</surname><given-names>M</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Netrin-1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson’s disease features</article-title><source>The EMBO Journal</source><volume>40</volume><elocation-id>e105537</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2020105537</pub-id><pub-id pub-id-type="pmid">33351190</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keino-Masu</surname><given-names>K</given-names></name><name><surname>Masu</surname><given-names>M</given-names></name><name><surname>Hinck</surname><given-names>L</given-names></name><name><surname>Leonardo</surname><given-names>ED</given-names></name><name><surname>Chan</surname><given-names>SS</given-names></name><name><surname>Culotti</surname><given-names>JG</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Deleted in colorectal cancer (DCC) encodes a netrin receptor</article-title><source>Cell</source><volume>87</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81336-7</pub-id><pub-id pub-id-type="pmid">8861902</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keleman</surname><given-names>K</given-names></name><name><surname>Dickson</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Short- and long-range repulsion by the <italic>Drosophila</italic> unc5 netrin receptor</article-title><source>Neuron</source><volume>32</volume><fpage>605</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(01)00505-0</pub-id><pub-id pub-id-type="pmid">11719202</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Stiles</surname><given-names>SG</given-names></name><name><surname>Feichtmeier</surname><given-names>JM</given-names></name><name><surname>Ramesh</surname><given-names>N</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Scalf</surname><given-names>MA</given-names></name><name><surname>Smith</surname><given-names>LM</given-names></name><name><surname>Pandey</surname><given-names>UB</given-names></name><name><surname>Tibbetts</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mutation-dependent aggregation and toxicity in a <italic>Drosophila</italic> model for UBQLN2-associated ALS</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>322</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx403</pub-id><pub-id pub-id-type="pmid">29161404</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klim</surname><given-names>JR</given-names></name><name><surname>Williams</surname><given-names>LA</given-names></name><name><surname>Limone</surname><given-names>F</given-names></name><name><surname>Guerra San Juan</surname><given-names>I</given-names></name><name><surname>Davis-Dusenbery</surname><given-names>BN</given-names></name><name><surname>Mordes</surname><given-names>DA</given-names></name><name><surname>Burberry</surname><given-names>A</given-names></name><name><surname>Steinbaugh</surname><given-names>MJ</given-names></name><name><surname>Gamage</surname><given-names>KK</given-names></name><name><surname>Kirchner</surname><given-names>R</given-names></name><name><surname>Moccia</surname><given-names>R</given-names></name><name><surname>Cassel</surname><given-names>SH</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Wainger</surname><given-names>BJ</given-names></name><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Eggan</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0300-4</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolodziej</surname><given-names>PA</given-names></name><name><surname>Timpe</surname><given-names>LC</given-names></name><name><surname>Mitchell</surname><given-names>KJ</given-names></name><name><surname>Fried</surname><given-names>SR</given-names></name><name><surname>Goodman</surname><given-names>CS</given-names></name><name><surname>Jan</surname><given-names>LY</given-names></name><name><surname>Jan</surname><given-names>YN</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Frazzled encodes a <italic>Drosophila</italic> member of the DCC immunoglobulin subfamily and is required for CNS and motor axon guidance</article-title><source>Cell</source><volume>87</volume><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81338-0</pub-id><pub-id pub-id-type="pmid">8861904</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korvatska</surname><given-names>O</given-names></name><name><surname>Leverenz</surname><given-names>JB</given-names></name><name><surname>Jayadev</surname><given-names>S</given-names></name><name><surname>McMillan</surname><given-names>P</given-names></name><name><surname>Kurtz</surname><given-names>I</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Rumbaugh</surname><given-names>M</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Girirajan</surname><given-names>S</given-names></name><name><surname>Dorschner</surname><given-names>MO</given-names></name><name><surname>Kiianitsa</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>C-E</given-names></name><name><surname>Brkanac</surname><given-names>Z</given-names></name><name><surname>Garden</surname><given-names>GA</given-names></name><name><surname>Raskind</surname><given-names>WH</given-names></name><name><surname>Bird</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>R47H variant of TREM2 associated with Alzheimer disease in a large late-onset family: clinical, genetic, and neuropathological study</article-title><source>JAMA Neurology</source><volume>72</volume><fpage>920</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2015.0979</pub-id><pub-id pub-id-type="pmid">26076170</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunita</surname><given-names>R</given-names></name><name><surname>Otomo</surname><given-names>A</given-names></name><name><surname>Mizumura</surname><given-names>H</given-names></name><name><surname>Suzuki-Utsunomiya</surname><given-names>K</given-names></name><name><surname>Hadano</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>J-E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The rab5 activator ALS2/alsin acts as a novel rac1 effector through rac1-activated endocytosis</article-title><source>The Journal of Biological Chemistry</source><volume>282</volume><fpage>16599</fpage><lpage>16611</lpage><pub-id pub-id-type="doi">10.1074/jbc.M610682200</pub-id><pub-id pub-id-type="pmid">17409386</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwiatkowski</surname><given-names>TJ</given-names></name><name><surname>Bosco</surname><given-names>DA</given-names></name><name><surname>Leclerc</surname><given-names>AL</given-names></name><name><surname>Tamrazian</surname><given-names>E</given-names></name><name><surname>Vanderburg</surname><given-names>CR</given-names></name><name><surname>Russ</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>A</given-names></name><name><surname>Gilchrist</surname><given-names>J</given-names></name><name><surname>Kasarskis</surname><given-names>EJ</given-names></name><name><surname>Munsat</surname><given-names>T</given-names></name><name><surname>Valdmanis</surname><given-names>P</given-names></name><name><surname>Rouleau</surname><given-names>GA</given-names></name><name><surname>Hosler</surname><given-names>BA</given-names></name><name><surname>Cortelli</surname><given-names>P</given-names></name><name><surname>de Jong</surname><given-names>PJ</given-names></name><name><surname>Yoshinaga</surname><given-names>Y</given-names></name><name><surname>Haines</surname><given-names>JL</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Ticozzi</surname><given-names>N</given-names></name><name><surname>Siddique</surname><given-names>T</given-names></name><name><surname>McKenna-Yasek</surname><given-names>D</given-names></name><name><surname>Sapp</surname><given-names>PC</given-names></name><name><surname>Horvitz</surname><given-names>HR</given-names></name><name><surname>Landers</surname><given-names>JE</given-names></name><name><surname>Brown</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mutations in the fus/tls gene on chromosome 16 cause familial amyotrophic lateral sclerosis</article-title><source>Science</source><volume>323</volume><fpage>1205</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1126/science.1166066</pub-id><pub-id pub-id-type="pmid">19251627</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labrador</surname><given-names>JP</given-names></name><name><surname>O’keefe</surname><given-names>D</given-names></name><name><surname>Yoshikawa</surname><given-names>S</given-names></name><name><surname>McKinnon</surname><given-names>RD</given-names></name><name><surname>Thomas</surname><given-names>JB</given-names></name><name><surname>Bashaw</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The homeobox transcription factor even-skipped regulates netrin-receptor expression to control dorsal motor-axon projections in <italic>Drosophila</italic></article-title><source>Current Biology</source><volume>15</volume><fpage>1413</fpage><lpage>1419</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.06.058</pub-id><pub-id pub-id-type="pmid">16085495</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanson</surname><given-names>NA</given-names><suffix>Jr</suffix></name><name><surname>Maltare</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Taylor</surname><given-names>JP</given-names></name><name><surname>Lloyd</surname><given-names>TE</given-names></name><name><surname>Pandey</surname><given-names>UB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A <italic>Drosophila</italic> model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43</article-title><source>Human Molecular Genetics</source><volume>20</volume><fpage>2510</fpage><lpage>2523</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr150</pub-id><pub-id pub-id-type="pmid">21487023</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>NTT</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Kovlyagina</surname><given-names>I</given-names></name><name><surname>Georgiou</surname><given-names>P</given-names></name><name><surname>Safren</surname><given-names>N</given-names></name><name><surname>Braunstein</surname><given-names>KE</given-names></name><name><surname>Kvarta</surname><given-names>MD</given-names></name><name><surname>Van Dyke</surname><given-names>AM</given-names></name><name><surname>LeGates</surname><given-names>TA</given-names></name><name><surname>Philips</surname><given-names>T</given-names></name><name><surname>Morrison</surname><given-names>BM</given-names></name><name><surname>Thompson</surname><given-names>SM</given-names></name><name><surname>Puche</surname><given-names>AC</given-names></name><name><surname>Gould</surname><given-names>TD</given-names></name><name><surname>Rothstein</surname><given-names>JD</given-names></name><name><surname>Wong</surname><given-names>PC</given-names></name><name><surname>Monteiro</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations</article-title><source>PNAS</source><volume>113</volume><fpage>E7580</fpage><lpage>E7589</lpage><pub-id pub-id-type="doi">10.1073/pnas.1608432113</pub-id><pub-id pub-id-type="pmid">27834214</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DY</given-names></name><name><surname>Arnott</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery</article-title><source>EMBO Reports</source><volume>14</volume><fpage>373</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1038/embor.2013.22</pub-id><pub-id pub-id-type="pmid">23459205</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leonardo</surname><given-names>ED</given-names></name><name><surname>Hinck</surname><given-names>L</given-names></name><name><surname>Masu</surname><given-names>M</given-names></name><name><surname>Keino-Masu</surname><given-names>K</given-names></name><name><surname>Ackerman</surname><given-names>SL</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Vertebrate homologues of <italic>C. elegans</italic> UNC-5 are candidate netrin receptors</article-title><source>Nature</source><volume>386</volume><fpage>833</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1038/386833a0</pub-id><pub-id pub-id-type="pmid">9126742</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Hartl</surname><given-names>FU</given-names></name><name><surname>Bracher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structure and function of hip, an attenuator of the Hsp70 chaperone cycle</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>20</volume><fpage>929</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2608</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Watson</surname><given-names>A</given-names></name><name><surname>Olechwier</surname><given-names>A</given-names></name><name><surname>Anaya</surname><given-names>M</given-names></name><name><surname>Sorooshyari</surname><given-names>SK</given-names></name><name><surname>Harnett</surname><given-names>DP</given-names></name><name><surname>Lee</surname><given-names>H-KP</given-names></name><name><surname>Vielmetter</surname><given-names>J</given-names></name><name><surname>Fares</surname><given-names>MA</given-names></name><name><surname>Garcia</surname><given-names>KC</given-names></name><name><surname>Özkan</surname><given-names>E</given-names></name><name><surname>Labrador</surname><given-names>J-P</given-names></name><name><surname>Zinn</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Deconstruction of the beaten path-sidestep interaction network provides insights into neuromuscular system development</article-title><source>eLife</source><volume>6</volume><elocation-id>e28111</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.28111</pub-id><pub-id pub-id-type="pmid">28829740</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>B-L</given-names></name><name><surname>Sun</surname><given-names>F-R</given-names></name><name><surname>Li</surname><given-names>J-Q</given-names></name><name><surname>Cao</surname><given-names>X-P</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The role of UNC5C in Alzheimer’s disease</article-title><source>Annals of Translational Medicine</source><volume>6</volume><elocation-id>178</elocation-id><pub-id pub-id-type="doi">10.21037/atm.2018.04.43</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>FeatureCounts: an efficient General purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>PJ</given-names></name><name><surname>Danner</surname><given-names>R</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Doong</surname><given-names>H</given-names></name><name><surname>Harman</surname><given-names>C</given-names></name><name><surname>Srinivasan</surname><given-names>D</given-names></name><name><surname>Rothenberg</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Monteiro</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD</article-title><source>The Journal of Cell Biology</source><volume>187</volume><fpage>201</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1083/jcb.200903024</pub-id><pub-id pub-id-type="pmid">19822669</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>SC</given-names></name><name><surname>Polymenidou</surname><given-names>M</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis</article-title><source>Neuron</source><volume>79</volume><fpage>416</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.033</pub-id><pub-id pub-id-type="pmid">23931993</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llambi</surname><given-names>F</given-names></name><name><surname>Causeret</surname><given-names>F</given-names></name><name><surname>Bloch-Gallego</surname><given-names>E</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Netrin-1 acts as a survival factor via its receptors UNC5H and DCC</article-title><source>The EMBO Journal</source><volume>20</volume><fpage>2715</fpage><lpage>2722</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.11.2715</pub-id><pub-id pub-id-type="pmid">11387206</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llambi</surname><given-names>F</given-names></name><name><surname>Lourenço</surname><given-names>FC</given-names></name><name><surname>Gozuacik</surname><given-names>D</given-names></name><name><surname>Guix</surname><given-names>C</given-names></name><name><surname>Pays</surname><given-names>L</given-names></name><name><surname>Del Rio</surname><given-names>G</given-names></name><name><surname>Kimchi</surname><given-names>A</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase</article-title><source>The EMBO Journal</source><volume>24</volume><fpage>1192</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600584</pub-id><pub-id pub-id-type="pmid">15729359</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-Seq data with deseq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The super elongation complex (SEC) family in transcriptional control</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>13</volume><fpage>543</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1038/nrm3417</pub-id><pub-id pub-id-type="pmid">22895430</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>XR</given-names></name><name><surname>Prudencio</surname><given-names>M</given-names></name><name><surname>Koike</surname><given-names>Y</given-names></name><name><surname>Vatsavayai</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Harbinski</surname><given-names>F</given-names></name><name><surname>Briner</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>CM</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Akiyama</surname><given-names>T</given-names></name><name><surname>Schmidt</surname><given-names>HB</given-names></name><name><surname>Cummings</surname><given-names>BB</given-names></name><name><surname>Wyatt</surname><given-names>DW</given-names></name><name><surname>Kurylo</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>G</given-names></name><name><surname>Mekhoubad</surname><given-names>S</given-names></name><name><surname>Sallee</surname><given-names>N</given-names></name><name><surname>Mekonnen</surname><given-names>G</given-names></name><name><surname>Ganser</surname><given-names>L</given-names></name><name><surname>Rubien</surname><given-names>JD</given-names></name><name><surname>Jansen-West</surname><given-names>K</given-names></name><name><surname>Cook</surname><given-names>CN</given-names></name><name><surname>Pickles</surname><given-names>S</given-names></name><name><surname>Oskarsson</surname><given-names>B</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name><name><surname>Boeve</surname><given-names>BF</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Shorter</surname><given-names>J</given-names></name><name><surname>Myong</surname><given-names>S</given-names></name><name><surname>Green</surname><given-names>EM</given-names></name><name><surname>Seeley</surname><given-names>WW</given-names></name><name><surname>Petrucelli</surname><given-names>L</given-names></name><name><surname>Gitler</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Tdp-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A</article-title><source>Nature</source><volume>603</volume><fpage>124</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04424-7</pub-id><pub-id pub-id-type="pmid">35197626</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melamed</surname><given-names>Z</given-names></name><name><surname>López-Erauskin</surname><given-names>J</given-names></name><name><surname>Baughn</surname><given-names>MW</given-names></name><name><surname>Zhang</surname><given-names>O</given-names></name><name><surname>Drenner</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Freyermuth</surname><given-names>F</given-names></name><name><surname>McMahon</surname><given-names>MA</given-names></name><name><surname>Beccari</surname><given-names>MS</given-names></name><name><surname>Artates</surname><given-names>JW</given-names></name><name><surname>Ohkubo</surname><given-names>T</given-names></name><name><surname>Rodriguez</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Bennett</surname><given-names>CF</given-names></name><name><surname>Rigo</surname><given-names>F</given-names></name><name><surname>Da Cruz</surname><given-names>S</given-names></name><name><surname>Ravits</surname><given-names>J</given-names></name><name><surname>Lagier-Tourenne</surname><given-names>C</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>180</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0293-z</pub-id><pub-id pub-id-type="pmid">30643298</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millikin</surname><given-names>RJ</given-names></name><name><surname>Solntsev</surname><given-names>SK</given-names></name><name><surname>Shortreed</surname><given-names>MR</given-names></name><name><surname>Smith</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ultrafast peptide label-free quantification with flashlfq</article-title><source>Journal of Proteome Research</source><volume>17</volume><fpage>386</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.7b00608</pub-id><pub-id pub-id-type="pmid">29083185</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millikin</surname><given-names>RJ</given-names></name><name><surname>Shortreed</surname><given-names>MR</given-names></name><name><surname>Scalf</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A Bayesian null interval hypothesis test controls false discovery rates and improves sensitivity in label-free quantitative proteomics</article-title><source>Journal of Proteome Research</source><volume>19</volume><fpage>1975</fpage><lpage>1981</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.9b00796</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>Y</given-names></name><name><surname>Futamura</surname><given-names>M</given-names></name><name><surname>Kitamura</surname><given-names>N</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Baba</surname><given-names>H</given-names></name><name><surname>Arakawa</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis</article-title><source>International Journal of Oncology</source><volume>36</volume><fpage>1253</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.3892/ijo_00000609</pub-id><pub-id pub-id-type="pmid">20372800</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>RI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>1427</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.1101/gad.1657108</pub-id><pub-id pub-id-type="pmid">18519635</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>D</given-names></name><name><surname>Kugler</surname><given-names>SJ</given-names></name><name><surname>Preiss</surname><given-names>A</given-names></name><name><surname>Maier</surname><given-names>D</given-names></name><name><surname>Nagel</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Genetic modifier screens on hairless gain-of-function phenotypes reveal genes involved in cell differentiation, cell growth and apoptosis in <italic>Drosophila melanogaster</italic></article-title><source>Genetics</source><volume>171</volume><fpage>1137</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1534/genetics.105.044453</pub-id><pub-id pub-id-type="pmid">16118195</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N’Diaye</surname><given-names>E-N</given-names></name><name><surname>Kajihara</surname><given-names>KK</given-names></name><name><surname>Hsieh</surname><given-names>I</given-names></name><name><surname>Morisaki</surname><given-names>H</given-names></name><name><surname>Debnath</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Plic proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation</article-title><source>EMBO Reports</source><volume>10</volume><fpage>173</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/embor.2008.238</pub-id><pub-id pub-id-type="pmid">19148225</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pakravan</surname><given-names>D</given-names></name><name><surname>Orlando</surname><given-names>G</given-names></name><name><surname>Bercier</surname><given-names>V</given-names></name><name><surname>Van Den Bosch</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis</article-title><source>Journal of Molecular Cell Biology</source><volume>13</volume><fpage>15</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1093/jmcb/mjaa049</pub-id><pub-id pub-id-type="pmid">32976566</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picher-Martel</surname><given-names>V</given-names></name><name><surname>Renaud</surname><given-names>L</given-names></name><name><surname>Bareil</surname><given-names>C</given-names></name><name><surname>Julien</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neuronal expression of ubqln2p497h exacerbates TDP-43 pathology in TDP-43g348c mice through interaction with ubiquitin</article-title><source>Molecular Neurobiology</source><volume>56</volume><fpage>4680</fpage><lpage>4696</lpage><pub-id pub-id-type="doi">10.1007/s12035-018-1411-3</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pradella</surname><given-names>D</given-names></name><name><surname>Deflorian</surname><given-names>G</given-names></name><name><surname>Pezzotta</surname><given-names>A</given-names></name><name><surname>Di Matteo</surname><given-names>A</given-names></name><name><surname>Belloni</surname><given-names>E</given-names></name><name><surname>Campolungo</surname><given-names>D</given-names></name><name><surname>Paradisi</surname><given-names>A</given-names></name><name><surname>Bugatti</surname><given-names>M</given-names></name><name><surname>Vermi</surname><given-names>W</given-names></name><name><surname>Campioni</surname><given-names>M</given-names></name><name><surname>Chiapparino</surname><given-names>A</given-names></name><name><surname>Scietti</surname><given-names>L</given-names></name><name><surname>Forneris</surname><given-names>F</given-names></name><name><surname>Giampietro</surname><given-names>C</given-names></name><name><surname>Volf</surname><given-names>N</given-names></name><name><surname>Rehman</surname><given-names>M</given-names></name><name><surname>Zacchigna</surname><given-names>S</given-names></name><name><surname>Paronetto</surname><given-names>MP</given-names></name><name><surname>Pistocchi</surname><given-names>A</given-names></name><name><surname>Eichmann</surname><given-names>A</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name><name><surname>Ghigna</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>4872</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-24998-6</pub-id><pub-id pub-id-type="pmid">34381052</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prahlad</surname><given-names>V</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Integrating the stress response: lessons for neurodegenerative diseases from <italic>C. elegans</italic></article-title><source>Trends in Cell Biology</source><volume>19</volume><fpage>52</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2008.11.002</pub-id><pub-id pub-id-type="pmid">19112021</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothenberg</surname><given-names>C</given-names></name><name><surname>Monteiro</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ubiquilin at a crossroads in protein degradation pathways</article-title><source>Autophagy</source><volume>6</volume><fpage>979</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.4161/auto.6.7.13118</pub-id><pub-id pub-id-type="pmid">20729634</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothenberg</surname><given-names>C</given-names></name><name><surname>Srinivasan</surname><given-names>D</given-names></name><name><surname>Mah</surname><given-names>L</given-names></name><name><surname>Kaushik</surname><given-names>S</given-names></name><name><surname>Peterhoff</surname><given-names>CM</given-names></name><name><surname>Ugolino</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Cuervo</surname><given-names>AM</given-names></name><name><surname>Nixon</surname><given-names>RA</given-names></name><name><surname>Monteiro</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy</article-title><source>Human Molecular Genetics</source><volume>19</volume><fpage>3219</fpage><lpage>3232</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq231</pub-id><pub-id pub-id-type="pmid">20529957</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>AB</given-names></name><name><surname>Lagleder</surname><given-names>S</given-names></name><name><surname>Gräwert</surname><given-names>MA</given-names></name><name><surname>Röhl</surname><given-names>A</given-names></name><name><surname>Hagn</surname><given-names>F</given-names></name><name><surname>Wandinger</surname><given-names>SK</given-names></name><name><surname>Cox</surname><given-names>MB</given-names></name><name><surname>Demmer</surname><given-names>O</given-names></name><name><surname>Richter</surname><given-names>K</given-names></name><name><surname>Groll</surname><given-names>M</given-names></name><name><surname>Kessler</surname><given-names>H</given-names></name><name><surname>Buchner</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The architecture of functional modules in the Hsp90 co-chaperone sti1/hop</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>1506</fpage><lpage>1517</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.472</pub-id><pub-id pub-id-type="pmid">22227520</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Şentürk</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Zuo</surname><given-names>Z</given-names></name><name><surname>Mao</surname><given-names>D</given-names></name><name><surname>Watson</surname><given-names>E</given-names></name><name><surname>Mikos</surname><given-names>AG</given-names></name><name><surname>Bellen</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ubiquilins regulate autophagic flux through mtor signalling and lysosomal acidification</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>384</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0281-x</pub-id><pub-id pub-id-type="pmid">30804504</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharkey</surname><given-names>LM</given-names></name><name><surname>Safren</surname><given-names>N</given-names></name><name><surname>Pithadia</surname><given-names>AS</given-names></name><name><surname>Gerson</surname><given-names>JE</given-names></name><name><surname>Dulchavsky</surname><given-names>M</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Lantis</surname><given-names>G</given-names></name><name><surname>Ashraf</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Meliki</surname><given-names>A</given-names></name><name><surname>Minakawa</surname><given-names>EN</given-names></name><name><surname>Barmada</surname><given-names>SJ</given-names></name><name><surname>Ivanova</surname><given-names>MI</given-names></name><name><surname>Paulson</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly</article-title><source>PNAS</source><volume>115</volume><fpage>E10495</fpage><lpage>E10504</lpage><pub-id pub-id-type="doi">10.1073/pnas.1810522115</pub-id><pub-id pub-id-type="pmid">30333186</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharkey</surname><given-names>LM</given-names></name><name><surname>Sandoval-Pistorius</surname><given-names>SS</given-names></name><name><surname>Moore</surname><given-names>SJ</given-names></name><name><surname>Gerson</surname><given-names>JE</given-names></name><name><surname>Komlo</surname><given-names>R</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Negron-Rios</surname><given-names>KY</given-names></name><name><surname>Crowley</surname><given-names>EV</given-names></name><name><surname>Padron</surname><given-names>F</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Murphy</surname><given-names>GG</given-names></name><name><surname>Paulson</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Modeling UBQLN2-mediated neurodegenerative disease in mice: shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity</article-title><source>Neurobiology of Disease</source><volume>143</volume><elocation-id>105016</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbd.2020.105016</pub-id><pub-id pub-id-type="pmid">32653673</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shortreed</surname><given-names>MR</given-names></name><name><surname>Wenger</surname><given-names>CD</given-names></name><name><surname>Frey</surname><given-names>BL</given-names></name><name><surname>Sheynkman</surname><given-names>GM</given-names></name><name><surname>Scalf</surname><given-names>M</given-names></name><name><surname>Keller</surname><given-names>MP</given-names></name><name><surname>Attie</surname><given-names>AD</given-names></name><name><surname>Smith</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Global identification of protein post-translational modifications in a single-pass database search</article-title><source>Journal of Proteome Research</source><volume>14</volume><fpage>4714</fpage><lpage>4720</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.5b00599</pub-id><pub-id pub-id-type="pmid">26418581</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siebert</surname><given-names>M</given-names></name><name><surname>Banovic</surname><given-names>D</given-names></name><name><surname>Goellner</surname><given-names>B</given-names></name><name><surname>Aberle</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>Drosophila</italic> motor axons recognize and follow a sidestep-labeled substrate pathway to reach their target fields</article-title><source>Genes &amp; Development</source><volume>23</volume><fpage>1052</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1101/gad.520509</pub-id><pub-id pub-id-type="pmid">19369411</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sink</surname><given-names>H</given-names></name><name><surname>Rehm</surname><given-names>EJ</given-names></name><name><surname>Richstone</surname><given-names>L</given-names></name><name><surname>Bulls</surname><given-names>YM</given-names></name><name><surname>Goodman</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Sidestep encodes a target-derived attractant essential for motor axon guidance in <italic>Drosophila</italic></article-title><source>Cell</source><volume>105</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)00296-3</pub-id><pub-id pub-id-type="pmid">11301002</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solntsev</surname><given-names>SK</given-names></name><name><surname>Shortreed</surname><given-names>MR</given-names></name><name><surname>Frey</surname><given-names>BL</given-names></name><name><surname>Smith</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Enhanced global post-translational modification discovery with metamorpheus</article-title><source>Journal of Proteome Research</source><volume>17</volume><fpage>1844</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.7b00873</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Synofzik</surname><given-names>M</given-names></name><name><surname>Maetzler</surname><given-names>W</given-names></name><name><surname>Grehl</surname><given-names>T</given-names></name><name><surname>Prudlo</surname><given-names>J</given-names></name><name><surname>Vom Hagen</surname><given-names>JM</given-names></name><name><surname>Haack</surname><given-names>T</given-names></name><name><surname>Rebassoo</surname><given-names>P</given-names></name><name><surname>Munz</surname><given-names>M</given-names></name><name><surname>Schöls</surname><given-names>L</given-names></name><name><surname>Biskup</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype</article-title><source>Neurobiology of Aging</source><volume>33</volume><elocation-id>2949</elocation-id><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.07.002</pub-id><pub-id pub-id-type="pmid">22892309</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Jang</surname><given-names>S-W</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>C-B</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>S-W</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Rama</surname><given-names>N</given-names></name><name><surname>Xiong</surname><given-names>W-C</given-names></name><name><surname>Mehlen</surname><given-names>P</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Netrin-1 mediates neuronal survival through PIKE-L interaction with the dependence receptor UNC5B</article-title><source>Nature Cell Biology</source><volume>10</volume><fpage>698</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1038/ncb1732</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanikawa</surname><given-names>C</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Arakawa</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>P53RDL1 regulates p53-dependent apoptosis</article-title><source>Nature Cell Biology</source><volume>5</volume><fpage>216</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1038/ncb943</pub-id><pub-id pub-id-type="pmid">12598906</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vactor</surname><given-names>DV</given-names></name><name><surname>Sink</surname><given-names>H</given-names></name><name><surname>Fambrough</surname><given-names>D</given-names></name><name><surname>Tsoo</surname><given-names>R</given-names></name><name><surname>Goodman</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Genes that control neuromuscular specificity in <italic>Drosophila</italic></article-title><source>Cell</source><volume>73</volume><fpage>1137</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90643-5</pub-id><pub-id pub-id-type="pmid">8513498</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vance</surname><given-names>C</given-names></name><name><surname>Rogelj</surname><given-names>B</given-names></name><name><surname>Hortobágyi</surname><given-names>T</given-names></name><name><surname>De Vos</surname><given-names>KJ</given-names></name><name><surname>Nishimura</surname><given-names>AL</given-names></name><name><surname>Sreedharan</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>B</given-names></name><name><surname>Ruddy</surname><given-names>D</given-names></name><name><surname>Wright</surname><given-names>P</given-names></name><name><surname>Ganesalingam</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>KL</given-names></name><name><surname>Tripathi</surname><given-names>V</given-names></name><name><surname>Al-Saraj</surname><given-names>S</given-names></name><name><surname>Al-Chalabi</surname><given-names>A</given-names></name><name><surname>Leigh</surname><given-names>PN</given-names></name><name><surname>Blair</surname><given-names>IP</given-names></name><name><surname>Nicholson</surname><given-names>G</given-names></name><name><surname>de Belleroche</surname><given-names>J</given-names></name><name><surname>Gallo</surname><given-names>JM</given-names></name><name><surname>Miller</surname><given-names>CC</given-names></name><name><surname>Shaw</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mutations in fus, an rna processing protein, cause familial amyotrophic lateral sclerosis type 6</article-title><source>Science</source><volume>323</volume><fpage>1208</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1126/science.1165942</pub-id><pub-id pub-id-type="pmid">19251628</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Es</surname><given-names>MA</given-names></name><name><surname>Veldink</surname><given-names>JH</given-names></name><name><surname>Saris</surname><given-names>CGJ</given-names></name><name><surname>Blauw</surname><given-names>HM</given-names></name><name><surname>van Vught</surname><given-names>PWJ</given-names></name><name><surname>Birve</surname><given-names>A</given-names></name><name><surname>Lemmens</surname><given-names>R</given-names></name><name><surname>Schelhaas</surname><given-names>HJ</given-names></name><name><surname>Groen</surname><given-names>EJN</given-names></name><name><surname>Huisman</surname><given-names>MHB</given-names></name><name><surname>van der Kooi</surname><given-names>AJ</given-names></name><name><surname>de Visser</surname><given-names>M</given-names></name><name><surname>Dahlberg</surname><given-names>C</given-names></name><name><surname>Estrada</surname><given-names>K</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Zwarts</surname><given-names>MJ</given-names></name><name><surname>van Doormaal</surname><given-names>PTC</given-names></name><name><surname>Rujescu</surname><given-names>D</given-names></name><name><surname>Strengman</surname><given-names>E</given-names></name><name><surname>Giegling</surname><given-names>I</given-names></name><name><surname>Muglia</surname><given-names>P</given-names></name><name><surname>Tomik</surname><given-names>B</given-names></name><name><surname>Slowik</surname><given-names>A</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Hendrich</surname><given-names>C</given-names></name><name><surname>Waibel</surname><given-names>S</given-names></name><name><surname>Meyer</surname><given-names>T</given-names></name><name><surname>Ludolph</surname><given-names>AC</given-names></name><name><surname>Glass</surname><given-names>JD</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Cichon</surname><given-names>S</given-names></name><name><surname>Nöthen</surname><given-names>MM</given-names></name><name><surname>Wichmann</surname><given-names>H-E</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Vermeulen</surname><given-names>SHHM</given-names></name><name><surname>Kiemeney</surname><given-names>LA</given-names></name><name><surname>Wokke</surname><given-names>JHJ</given-names></name><name><surname>Cronin</surname><given-names>S</given-names></name><name><surname>McLaughlin</surname><given-names>RL</given-names></name><name><surname>Hardiman</surname><given-names>O</given-names></name><name><surname>Fumoto</surname><given-names>K</given-names></name><name><surname>Pasterkamp</surname><given-names>RJ</given-names></name><name><surname>Meininger</surname><given-names>V</given-names></name><name><surname>Melki</surname><given-names>J</given-names></name><name><surname>Leigh</surname><given-names>PN</given-names></name><name><surname>Shaw</surname><given-names>CE</given-names></name><name><surname>Landers</surname><given-names>JE</given-names></name><name><surname>Al-Chalabi</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>RH</given-names><suffix>Jr</suffix></name><name><surname>Robberecht</surname><given-names>W</given-names></name><name><surname>Andersen</surname><given-names>PM</given-names></name><name><surname>Ophoff</surname><given-names>RA</given-names></name><name><surname>van den Berg</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genome-Wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis</article-title><source>Nature Genetics</source><volume>41</volume><fpage>1083</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1038/ng.442</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van’t Spijker</surname><given-names>HM</given-names></name><name><surname>Almeida</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>How villains are made: the translation of dipeptide repeat proteins in C9ORF72-ALS/FTD</article-title><source>Gene</source><volume>858</volume><elocation-id>147167</elocation-id><pub-id pub-id-type="doi">10.1016/j.gene.2023.147167</pub-id><pub-id pub-id-type="pmid">36621656</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Chan</surname><given-names>L-N</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Autoinhibition of UNC5B revealed by the cytoplasmic domain structure of the receptor</article-title><source>Molecular Cell</source><volume>33</volume><fpage>692</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.02.016</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wetzel-Smith</surname><given-names>MK</given-names></name><name><surname>Hunkapiller</surname><given-names>J</given-names></name><name><surname>Bhangale</surname><given-names>TR</given-names></name><name><surname>Srinivasan</surname><given-names>K</given-names></name><name><surname>Maloney</surname><given-names>JA</given-names></name><name><surname>Atwal</surname><given-names>JK</given-names></name><name><surname>Sa</surname><given-names>SM</given-names></name><name><surname>Yaylaoglu</surname><given-names>MB</given-names></name><name><surname>Foreman</surname><given-names>O</given-names></name><name><surname>Ortmann</surname><given-names>W</given-names></name><name><surname>Rathore</surname><given-names>N</given-names></name><name><surname>Hansen</surname><given-names>DV</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name><name><surname>Pericak-Vance</surname><given-names>M</given-names></name><name><surname>Haines</surname><given-names>J</given-names></name><name><surname>Farrer</surname><given-names>LA</given-names></name><name><surname>Schellenberg</surname><given-names>GD</given-names></name><name><surname>Goate</surname><given-names>A</given-names></name><name><surname>Behrens</surname><given-names>TW</given-names></name><name><surname>Cruchaga</surname><given-names>C</given-names></name><name><surname>Watts</surname><given-names>RJ</given-names></name><name><surname>Graham</surname><given-names>RR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A rare mutation in unc5c predisposes to late-onset alzheimer’s disease and increases neuronal cell death</article-title><source>Nature Medicine</source><volume>20</volume><fpage>1452</fpage><lpage>1457</lpage><pub-id pub-id-type="doi">10.1038/nm.3736</pub-id><pub-id pub-id-type="pmid">25419706</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>ME</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>McKenna</surname><given-names>WL</given-names></name><name><surname>Washington</surname><given-names>R</given-names></name><name><surname>Boyette</surname><given-names>A</given-names></name><name><surname>Strickland</surname><given-names>P</given-names></name><name><surname>Dillon</surname><given-names>A</given-names></name><name><surname>Kaprielian</surname><given-names>Z</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Hinck</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>UNC5A promotes neuronal apoptosis during spinal cord development independent of netrin-1</article-title><source>Nature Neuroscience</source><volume>9</volume><fpage>996</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1038/nn1736</pub-id><pub-id pub-id-type="pmid">16829956</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>MD</given-names></name><name><surname>Sethi</surname><given-names>S</given-names></name><name><surname>Lein</surname><given-names>PJ</given-names></name><name><surname>Keil</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Valid statistical approaches for analyzing sholl data: mixed effects versus simple linear models</article-title><source>Journal of Neuroscience Methods</source><volume>279</volume><fpage>33</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2017.01.003</pub-id><pub-id pub-id-type="pmid">28104486</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiśniewski</surname><given-names>JR</given-names></name><name><surname>Zougman</surname><given-names>A</given-names></name><name><surname>Nagaraj</surname><given-names>N</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Universal sample preparation method for proteome analysis</article-title><source>Nature Methods</source><volume>6</volume><fpage>359</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1322</pub-id><pub-id pub-id-type="pmid">19377485</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittwer</surname><given-names>F</given-names></name><name><surname>van der Straten</surname><given-names>A</given-names></name><name><surname>Keleman</surname><given-names>K</given-names></name><name><surname>Dickson</surname><given-names>BJ</given-names></name><name><surname>Hafen</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth</article-title><source>Development</source><volume>128</volume><fpage>791</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1242/dev.128.5.791</pub-id><pub-id pub-id-type="pmid">11171403</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>X-G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pathogenic ubqln2 gains toxic properties to induce neuron death</article-title><source>Acta Neuropathologica</source><volume>129</volume><fpage>417</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1367-y</pub-id><pub-id pub-id-type="pmid">25388785</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Petersen</surname><given-names>AJ</given-names></name><name><surname>Soref</surname><given-names>C</given-names></name><name><surname>Richards</surname><given-names>WD</given-names></name><name><surname>Ludwig</surname><given-names>T</given-names></name><name><surname>Taapken</surname><given-names>S</given-names></name><name><surname>Berndt</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>S-C</given-names></name><name><surname>Bhattacharyya</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Generation of seven induced pluripotent stem cell lines from neonates of different ethnic backgrounds</article-title><source>Stem Cell Research</source><volume>34</volume><elocation-id>101365</elocation-id><pub-id pub-id-type="doi">10.1016/j.scr.2018.101365</pub-id><pub-id pub-id-type="pmid">30605841</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuva-Aydemir</surname><given-names>Y</given-names></name><name><surname>Almeida</surname><given-names>S</given-names></name><name><surname>Krishnan</surname><given-names>G</given-names></name><name><surname>Gendron</surname><given-names>TF</given-names></name><name><surname>Gao</surname><given-names>FB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>5466</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13477-8</pub-id><pub-id pub-id-type="pmid">31784536</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Hanson</surname><given-names>KA</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Tare</surname><given-names>A</given-names></name><name><surname>Tibbetts</surname><given-names>RS</given-names></name><name><surname>Tear</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identification of genetic modifiers of TDP-43 neurotoxicity in <italic>Drosophila</italic></article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e57214</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0057214</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Castañeda</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structure, dynamics and functions of ubqlns: at the crossroads of protein quality control machinery</article-title><source>The Biochemical Journal</source><volume>477</volume><fpage>3471</fpage><lpage>3497</lpage><pub-id pub-id-type="doi">10.1042/BCJ20190497</pub-id><pub-id pub-id-type="pmid">32965492</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Pache</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Khodabakhshi</surname><given-names>AH</given-names></name><name><surname>Tanaseichuk</surname><given-names>O</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Chanda</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1523</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zientara-Rytter</surname><given-names>K</given-names></name><name><surname>Subramani</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The roles of ubiquitin-binding protein shuttles in the degradative fate of ubiquitinated proteins in the ubiquitin-proteasome system and autophagy</article-title><source>Cells</source><volume>8</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.3390/cells8010040</pub-id><pub-id pub-id-type="pmid">30634694</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84382.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chin</surname><given-names>Jeannie</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Baylor College of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.10.31.514355" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.31.514355"/></front-stub><body><p>This valuable study carried out a genetic screening of <italic>Drosophila</italic> lines expressing wild-type or ALS/FTD mutations of ubiquilin 2 and identified several suppressors and enhancers of ubiquilin 2 phenotypes. The study particularly focused on two genes involved in axon guidance pathways, unc5, and beat-1b. The evidence supporting the conclusions is solid and will be of interest to a broad audience studying ALS/FTD and neurodegenerative diseases.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84382.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chin</surname><given-names>Jeannie</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pttbw34</institution-id><institution>Baylor College of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Zhu</surname><given-names>Haining</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03m2x1q45</institution-id><institution>University of Arizona</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.10.31.514355">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.10.31.514355v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Jeannie Chin as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Haining Zhu (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>In addition to addressing the specific comments of the Reviewers (reviews appended below), please address these Essential Revisions below.</p><p>1) Much of the data presented is qualitative, without proper quantification and statistical analysis. All data need to be quantified and presented with appropriate statistics.</p><p>2) The heat shock effect in the <italic>Drosophila</italic> lines was not clear in the study. Why did some lines show phenotypes only at 29C but not 22C? Ubiquilin 2 expression was not impacted by 29C, then what caused the phenotypic differences? In the method sections please describe clearly whether a temperature sensitive promoter was used in the flies.</p><p>3) Data on male and female flies were shown separately in some but not all experiments. Please discuss whether there was a sex difference in those experiments.</p><p>4) Quite bit of data presented appear to be peripheral with no significant contribution to the main findings. Moreover, some data were introduced but were not explained. For instance, the RNA-Seq analysis (Figure 2) did not contribute much to the study. The rescue effect of UBA* (F594A mutant) in Figure 1-Supplemental 1B was interesting but was not elaborated or followed up. FUS flies in Figure 6-Supplement 2 were abruptly introduced with little discussion. Please remove data that is unrelated to the main findings of the paper. Some data can be moved to the Supplemental data, but only if they are integrate well with the story and are clearly described.</p><p>5) The main quadrupole (4xALS) mutation used in the study was not found in patients. The relevance of the findings needs to be thoroughly justified.</p><p>6) ALS and FTD are age-related neurodegenerative diseases, whereas the involvement of axon guidance genes in indicative of disruptions during the developmental stage. Please discuss this potential caveat.</p><p>7) If new lines were made for this paper, then proper characterization should be presented (staminality markers etc).</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Specific comments on individual figures.</p><p>Figure 1:</p><p>(1) Can the eye phenotype be quantified? Some mutations appeared to cause relatively minor phenotypes.</p><p>(2) Any sex differences? Why so?</p><p>(3) No data were presented for I498X flies.</p><p>(4) Why did UBA* (F594A) rescued the phenotype?</p><p>(5) It appears that ubiquilin 2-UBA* was exclusively outside the nucleus in images shown in Supplement 1C. Why?</p><p>(6) &quot;single copy&quot; &quot;two copies&quot; used in the first paragraph of the Results section (page 5) are confusing. Did they refer to the number of copies of transgene in flies? Or did they refer to single, double, or quadrupole mutations? This needs to be clarified.</p><p>(7) Most importantly, what caused the heat shock effect (29C vs 22C) on the phenotypes? The study ruled out the effect of temperature on ubiquilin 2 expression, but did not provide any explanation for this interesting observation.</p><p>Figure 2: The data are loosely related and don't contribute much to the study.</p><p>Figure 4: Why shRab5 only showed effect in 4xALS flies at 29C but not 22C? Why did shRab5 showed effect at both 22C and 29C in WT and P497H flies?</p><p>Figure 5: What temperature was used for Figure 5B? 22C or 29C?</p><p>Figure 7:</p><p>(1) Any sex differences? Why so?</p><p>(2) D42-Gal4 or D42-WT ubiquilin 2 should be included as a control in Figure 7B-C.</p><p>(3) Supplement 3. Two blues curves are too similar. A different color is suggested so that they can be easily distinguished. In addition, Elev-shUnc5 appeared to have a marginal effect in females (panel B).</p><p>Figure 9: The western blot results need to be quantified to better understand the effects described in the text.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>– All WB and eye phenotype need quantification whenever a comparison is made. All data should be accompanied by quantification graphs, showing statistical significances etc.</p><p>– Mass Spec in figure 1 needs stats.</p><p>– page 8 line 20: why should GFP-Rab5 rescue the eye phenotype of the UBQLN2wt and p497h which do not have eye phenotype at 29{degree sign} (according to Figure 1)?</p><p>– Figure suppl 1 C: why is here a ELAV promoter used? In the 4XALS, UBQLN2 is greatly aggregating. This I am sure will be reflected in a sol/insol RIPA extraction which has not been performed with this particular mutant under this particular promoter.</p><p>– Figure 2: I totally miss the relevance of this figure for the entire paper. That the flies are different is clear from the eye degeneration phenotype. When the reader comes to this figure, he/she is brought to try to find the connection with the rest of the paper which is hard to find. It would be more relevant for example to show if the suppressor and the enhancer found in the screening are different in this RNAseq data. Moreover, I think in Figure 2B that the reference group to compare all the other should be GMR and not WT. The background is for all GMR not WT so for which reason did the authors compare all the group to the WT and then build the Venn diagram? I think this is a mistake and might lead to misleading findings.</p><p>– Figures 4 and 5 are a nice validation of the screening, but since the findings are no further investigated these figures might be better put in the supplementary.</p><p>– Figure 6D: WB for Unc5 missing.</p><p>– Figure suppl 3 should be moved in the main figure 7.</p><p>– Figure 9: if these are new lines made for this paper a proper characterization should be presented (staminality markers etc). Besides this, the entire figure 9 should go in the supplementary as it functions only as a support for the data in the neurons. I also struggle to see the value of all the data with the BafA1 and of the lysosome analysis if they are no reproduced in neurons.</p><p>– Figure suppl 8 is missing the WB for DCC to show reduced level of the protein as well as of the RNA.</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by David Ron (Senior Editor) and a Reviewing Editor, as well as the original Reviewers.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>1. Please include the Eye Degeneration Score in all of the figures. It can perhaps be omitted in the screening to avoid making the figure too dense, but it will be helpful in the other figures to ensure that people outside of the fly field can evaluate the differences. Including the Eye Degeneration Score will also allow evaluation of the consistency of the findings across experiments.</p><p>2. Please ensure that the Images of the fly eyes have high enough resolution to be clear (for example, Figure 3 Supplementary 1 is clear).</p><p>3. Please include a quantification of Figure 8C: if a decreased co-localization with these markers is claimed, Pearson's coefficient or fluorescence intensity should be added.</p><p>4. Consider revising the choice of key words for this work to better reflect the content of the paper.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.84382.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>In addition to addressing the specific comments of the Reviewers (reviews appended below), please address these Essential Revisions below.</p><p>1) Much of the data presented is qualitative, without proper quantification and statistical analysis. All data need to be quantified and presented with appropriate statistics.</p></disp-quote><p>We have added multiple replicates, quantifications and additional statistical analyses for several figures in which we claimed a difference between experimental samples (Figure 1—figure supplement 1B, 1C, Figure 2—figure supplement 1E, 1H, Figure 2—figure supplement 2C, Figure 3E, Figure 5F, and Figure 6E). Western blots showing UBQLN2 fractionation in iPSCs (Figure 6A) were quantified but we did not statistically analyze the data because the amount of UBQLN2 in the insoluble fractions was consistently too low for confident analysis. However, we added the triplicate western blotting data to the Figure 6A source data. In those instances where insoluble UBQLN2 was detected, the band intensity was qualitatively the same across all experimental genotypes.</p><disp-quote content-type="editor-comment"><p>2) The heat shock effect in the <italic>Drosophila</italic> lines was not clear in the study. Why did some lines show phenotypes only at 29C but not 22C? Ubiquilin 2 expression was not impacted by 29C, then what caused the phenotypic differences? In the method sections please describe clearly whether a temperature sensitive promoter was used in the flies.</p></disp-quote><p>Figure 1—figure supplement 1C: The heat inducibility of the UBQLN2 transgenes, including UBQLN2<sup>4XALS</sup> can be partly attributed to heat shock elements in the UAS promoter. This was noted in the text (page 6, line 4-14) and has been highlighted in the revised Materials and methods (page 25, line 6-8). The heat inducibility of dUbqln is interesting and may reflect transcriptional and/or posttranscriptional mechanisms. While it is possible that increased UBQLN2 contributes to the severe phenotypes in UBQLN2<sup>4XALS</sup> flies reared at 29°C; this is not seen for UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> flies. Instead, we postulate that heat stress synergizes with the misfolded UBQLN2<sup>4XALS</sup> protein to disrupt proteostasis and endolysosomal function. We have added a point on this matter in paragraph 2 of the Discussion (page 16, line 15-25) section of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3) Data on male and female flies were shown separately in some but not all experiments. Please discuss whether there was a sex difference in those experiments.</p></disp-quote><p>UBQLN2<sup>4XALS</sup>-associated toxicity phenotypes were seen in both sexes across all phenotypic assays; however, subtle sex differences were observed in two experiments. In Figure 4D, Unc-5 silencing extended the lifespan of Elav&gt;Gal4 female control flies but not Elav&gt;Gal4 male control flies and, in Figure 4A, an Unc-5 KK RNAi line rescued climbing of D42&gt;UBQLN2<sup>4XALS</sup> male flies, but not female flies (a second Unc-5 RNAi line rescued both males and females). The sexual dimorphic phenotype in this experiment was noted in the results p10, line 20-21.</p><disp-quote content-type="editor-comment"><p>4) Quite bit of data presented appear to be peripheral with no significant contribution to the main findings. Moreover, some data were introduced but were not explained. For instance, the RNA-Seq analysis (Figure 2) did not contribute much to the study. The rescue effect of UBA* (F594A mutant) in Figure 1-Supplemental 1B was interesting but was not elaborated or followed up. FUS flies in Figure 6-Supplement 2 were abruptly introduced with little discussion. Please remove data that is unrelated to the main findings of the paper. Some data can be moved to the Supplemental data, but only if they are integrate well with the story and are clearly described.</p></disp-quote><p>We understand the reviewer’s point or the reviewer’s point is well taken. Appreciating the reviewer’s comment, we moved both figures to the supplementary data.</p><p>RNA-Seq (Figure 1—figure supplement 2)</p><p>Although not essential, the RNA-Seq adds experimental rigor to the study by providing strong molecular correlates to eye degeneration phenotypes across different UBQLN2 genotypes. It shows the unique toxicity of UBQLN2<sup>4XALS</sup> and reinforces phenotypic similarity between UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> flies, which likely reflects non-specific toxicity of overexpressed UBQLN2 proteins. We have carried out additional data analyses requested by the reviewer and moved the RNA-Seq data to Figure 1—figure supplement 2.</p><p>Lack of genetic interaction between FUS and Unc-5 (Figure 3—figure supplement 1).</p><p>This data was included to show that shUnc-5 is not a general suppressor of eye toxicity in <italic>Drosophila</italic>. This contrasts with <italic>lilliputian</italic>, whose mutation rescues toxicity phenotypes elicited by FUS, TDP-43, and UBQLN2. We believe that the FUS control data enhances experimental rigor and have retained the data in the revised manuscript, with some additional clarification on page 10, line 3-7.</p><p>UBA mutant (Figure1—figure supplement 1).</p><p>Both aggregation and toxicity of UBQLN2<sup>4XALS</sup> were abolished by a F594A mutation in the UBA domain that abolishes Ub binding. However, as the reviewer noted, we did not follow up on the finding and have therefore chosen to remove it from the revised manuscript.</p><disp-quote content-type="editor-comment"><p>5) The main quadrupole (4xALS) mutation used in the study was not found in patients. The relevance of the findings needs to be thoroughly justified.</p></disp-quote><p>The use of combinatorial mutants—either in the same gene or same pathway—can sometimes be used to enhance neurodegenerative phenotypes in cellular and rodent models for neurodegenerative diseases, most notably, Alzheimer’s Disease. In the case of the 4XALS mutant, we reasoned that its enhanced aggregation might drive stronger phenotypes than those elicited by UBQLN2 clinical alleles, whose toxicity is marginally discernible from overexpressed UBQLN2<sup>WT</sup>. We have clarified the rationale for testing the 4XALS mutant and articulated its potential strengths and weaknesses in Results (page 5, line 14-page 6, line 2) and Discussion (page 16, line 15-25) sections.</p><disp-quote content-type="editor-comment"><p>6) ALS and FTD are age-related neurodegenerative diseases, whereas the involvement of axon guidance genes in indicative of disruptions during the developmental stage. Please discuss this potential caveat.</p></disp-quote><p>We have inserted the following sentence in the discussion to note this caveat:</p><p>“Consistent with this notion, <italic>UNC5B</italic> has been linked to neurodegeneration in the 6-OHDA model of Parkinson’s Disease (PD) and <italic>UNC5C</italic> has been nominated as a risk allele in late-onset Alzheimer’s Disease. Defining the contributions of pathologic UNC5 signaling to the development or progression of ALS-dementia awaits further study.” on Page 20, line 2-6.</p><p>We have added a similar sentence to the Limitations paragraph at the end of the Discussion:</p><p>“Third, it is possible that axon guidance genes are only relevant to UBQLN2 toxicity in the context of the developing nervous system”.</p><disp-quote content-type="editor-comment"><p>7) If new lines were made for this paper, then proper characterization should be presented (staminality markers etc).</p></disp-quote><p>All lines are derived from a male iPSC line that has been karyotyped and characterized for stemness and differentiation potential (Yin et al. (2019) Stem Cell Res 34, 101365.)(1). We also karyotyped the P497H, 2XALS, and 4XALS Clone 1 line used throughout the paper.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Specific comments on individual figures.</p><p>Figure 1:</p><p>(1) Can the eye phenotype be quantified? Some mutations appeared to cause relatively minor phenotypes.</p></disp-quote><p>For the genetic screen we scored the rough eye phenotype according to the rubric shown in Figure 2B. For subsequent eye morphology studies, we simply relied on qualitative differences between UBQLN2<sup>4XALS</sup> flies in the absence or presence of different test mutations. While this type of qualitative analyses is standard in the field and generally worked well for our studies, it lacks the power to distinguish subtle phenotypic differences between different mutants and we generally did not follow up on mutants that showed marginal effects. As a consequence, our screen likely missed weak modifiers of the UBQLN2<sup>4XALS</sup> phenotype. To reduce confounding effects of genetic background differences we performed a side-by-side comparison of F1 progeny harboring the UBQLN2<sup>ALS</sup> transgene and test mutation/chromosome or the UBQLN2<sup>ALS</sup> transgene and control (e.g. balancer) chromosome.</p><disp-quote content-type="editor-comment"><p>(2) Any sex differences? Why so?</p></disp-quote><p>UBQLN2<sup>4XALS</sup> was toxic in both male and female flies under all experimental conditions and UBQLN2 modifier genes yielded similar phenotypes in both male and female flies with a couple of exceptions. For example, Unc-5 silencing extended the lifespan of control Elav&gt;Gal4 male flies, but not control female Elav&gt;Gal4 flies (Figure 4D), and a validating Unc-5 RNAi line (KK) strongly rescued the climbing phenotype of male, but not female D42&gt;UBQLN2<sup>4XALS</sup> flies (Figure 4A). The reasons for these differences are not clear.</p><disp-quote content-type="editor-comment"><p>(3) No data were presented for I498X flies.</p></disp-quote><p>We did not generate I498X flies, only the I498X iPSC line which was a byproduct of UBQLN2 CRISPR mutagenesis.</p><disp-quote content-type="editor-comment"><p>(4) Why did UBA* (F594A) rescued the phenotype?</p></disp-quote><p>The simplest explanation is that UBQLN2<sup>4XALS</sup> must bind to Ub—possibly in the form of ubiquitylated substrates—to aggregate in cells. Another (less interesting) explanation is that the UBA* mutation destabilizes UBQLN2<sup>4XALS</sup> such that it does not accumulate to levels required for its aggregation. Regardless, we agree that the UBA data is peripheral to the main story and removed Figure 1—figure supplement 1B, and 1C from the revised manuscript.</p><disp-quote content-type="editor-comment"><p>(5) It appears that ubiquilin 2-UBA* was exclusively outside the nucleus in images shown in Supplement 1C. Why?</p></disp-quote><p>This is an interesting point that we had not noted previously. We may revisit this result in future studies.</p><disp-quote content-type="editor-comment"><p>(6) &quot;single copy&quot; &quot;two copies&quot; used in the first paragraph of the Results section (page 5) are confusing. Did they refer to the number of copies of transgene in flies? Or did they refer to single, double, or quadrupole mutations? This needs to be clarified.</p></disp-quote><p>We apologize for the lack of clarity. We generated flies harboring single-copy UAS-UBQLN2 transgenes on Chr2 and Chr3 that were then recombined with different Gal4 driver lines. We have replaced the confusing language on page 5, line 14-page 6 line 2 with the more appropriate terms “hemizygous” and “homozygous” to describe flies harboring one or two UBQLN2 alleles. We have also elaborated on the construction of the flies in the Materials and methods section.</p><disp-quote content-type="editor-comment"><p>(7) Most importantly, what caused the heat shock effect (29C vs 22C) on the phenotypes? The study ruled out the effect of temperature on ubiquilin 2 expression, but did not provide any explanation for this interesting observation.</p></disp-quote><p>The most plausible hypothesis is that heat stress synergizes with the misfolded UBQLN2<sup>4XALS</sup> protein to disrupt proteostasis and/or endolysosomal function. The following clarifying language has been added to paragraph 2 of the Discussion (page 16, line 15-25): “The reason for enhanced toxicity of UBQLN2<sup>4XALS</sup> is unclear; however, its enhanced aggregation potential may overwhelm cellular proteostasis machinery and/or accelerate disease mechanisms that are slow to manifest in neurons harboring ALS point mutations. This is consistent with the fact that UBQLN2<sup>4XALS</sup> toxicity in flies was unmasked by HS, which is a well-known inducer of proteotoxicity.” We have also explicitly state the HS inducibility of the UAS-Gal4 in the Materials and methods (page 25, line 6-8).</p><disp-quote content-type="editor-comment"><p>Figure 2: The data are loosely related and don't contribute much to the study.</p></disp-quote><p>Although not essential, the RNA-Seq adds experimental rigor to the study by providing strong molecular correlates to eye degeneration phenotypes across different UBQLN2 genotypes. It shows the unique toxicity of UBQLN2<sup>4XALS</sup> and reinforces phenotypic similarity between UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> flies, which likely reflects non-specific toxicity of overexpressed UBQLN2 proteins. We have carried out additional data analyses requested by the reviewer (Figure 1—figure supplement 2A) and moved the RNA-Seq data to Figure 1—figure supplement 2.</p><disp-quote content-type="editor-comment"><p>Figure 4: Why shRab5 only showed effect in 4xALS flies at 29C but not 22C? Why did shRab5 showed effect at both 22C and 29C in WT and P497H flies?</p></disp-quote><p>Although there are several possibilities, we speculate that the enhanced solubility of UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> (relative to UBQLN2<sup>4XALS</sup>) leads to a greater disruption of the ubiquitin and endolysosomal pathways at room temperature (as reported Kim et al., Human Molecular Genetics, 2018, Vol. 27, No. 2 p322–337)(2). As a consequence, UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> lines are more sensitive to reductions in Rab5 gene dosage than UBQLN2<sup>4XALS</sup> flies at room temperature. We have attempted to clarify this in the Results (page 8, line 21-26) and Discussion (page 19, line 4-7) of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Figure 5: What temperature was used for Figure 5B? 22C or 29C?</p></disp-quote><p>The experiment was carried out at 29°C. We added specific details to the figure legend.</p><disp-quote content-type="editor-comment"><p>Figure 7:</p><p>(2) D42-Gal4 or D42-WT ubiquilin 2 should be included as a control in Figure 7B-C.</p></disp-quote><p>We added data for the D42-Gal4 control in Figure 4B and 4C.</p><disp-quote content-type="editor-comment"><p>(3) Supplement 3. Two blues curves are too similar. A different color is suggested so that they can be easily distinguished. In addition, Elev-shUnc5 appeared to have a marginal effect in females (panel B).</p></disp-quote><p>We made the suggested color change. shUnc-5 silencing increased lifespan of males and female flies (now presented in Figure 4D).</p><disp-quote content-type="editor-comment"><p>Figure 9: The western blot results need to be quantified to better understand the effects described in the text.</p></disp-quote><p>We have added multiple replicates, quantifications and additional statistical analyses for several figures in which we claimed a difference between experimental samples (Figure 1—figure supplement 1B, 1C, Figure 2—figure supplement 1E, 1H, Figure 2—figure supplement 2C, Figure 3E, Figure 5F, and Figure 6E). Western blots showing UBQLN2 fractionation in iPSCs (Figure 6A) were quantified but we did not statistically analyze the data because the amount of UBQLN2 in the insoluble fractions was consistently too low for confident analysis. However, we added the triplicate western blotting data to the Figure 6A source data. In those instances where insoluble UBQLN2 was detected, the band intensity was qualitatively the same across all experimental genotypes.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>– All WB and eye phenotype need quantification whenever a comparison is made. All data should be accompanied by quantification graphs, showing statistical significances etc.</p></disp-quote><p>We have added multiple replicates, quantifications and additional statistical analyses for several figures in which we claimed a difference between experimental samples (Figure 1—figure supplement 1B, 1C, Figure 2—figure supplement 1E, 1H, Figure 2—figure supplement 2C, Figure 3E, Figure 5F, and Figure 6E). Western blots showing UBQLN2 fractionation in iPSCs (Figure 6A) were quantified but we did not statistically analyze the data because the amount of UBQLN2 in the insoluble fractions was consistently too low for confident analysis. However, we added the triplicate western blotting data to the Figure 6A source data. In those instances where insoluble UBQLN2 was detected, the band intensity was qualitatively the same across all experimental genotypes.</p><disp-quote content-type="editor-comment"><p>– Mass Spec in figure 1 needs stats.</p></disp-quote><p>This has been added.</p><disp-quote content-type="editor-comment"><p>– page 8 line 20: why should GFP-Rab5 rescue the eye phenotype of the UBQLN2wt and p497h which do not have eye phenotype at 29{degree sign} (according to Figure 1)?</p></disp-quote><p>Although there are several possibilities, we speculate that the enhanced solubility of UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> (relative to UBQLN2<sup>4XALS</sup>) leads to a greater disruption of the ubiquitin and endolysosomal pathways at room temperature (as reported Kim et al., Human Molecular Genetics, 2018, Vol. 27, No. 2 p322–337)(2). As a consequence, UBQLN2<sup>WT</sup> and UBQLN2<sup>P497H</sup> lines are more sensitive to reductions in Rab5 gene dosage than UBQLN2<sup>4XALS</sup> flies at room temperature. We have attempted to clarify this in the Results (page 8, line 21-26) and Discussion (page 19, line 4-7) of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>– Figure suppl 1 C: why is here a ELAV promoter used? In the 4XALS, UBQLN2 is greatly aggregating. This I am sure will be reflected in a sol/insol RIPA extraction which has not been performed with this particular mutant under this particular promoter.</p></disp-quote><p>Elav was used to examine UBQLN2 aggregation in the brain. Although not shown in this paper, we previously published the RIPA insolubility of UBQLN2<sup>4XALS</sup> expressed in fly brains under control of Elav (Kim et al., Human Molecular Genetics, 2018, Vol. 27, No. 2 p322–337 Figure 4A) (2). Figure 1—figure supplement 1A, B has been modified to focus on the expression of wild-type and mutant UBQLN2 proteins expressed under control of GMR at 22°C and 29°C.</p><disp-quote content-type="editor-comment"><p>– Figure 2: I totally miss the relevance of this figure for the entire paper. That the flies are different is clear from the eye degeneration phenotype. When the reader comes to this figure, he/she is brought to try to find the connection with the rest of the paper which is hard to find. It would be more relevant for example to show if the suppressor and the enhancer found in the screening are different in this RNAseq data. Moreover, I think in Figure 2B that the reference group to compare all the other should be GMR and not WT. The background is for all GMR not WT so for which reason did the authors compare all the group to the WT and then build the Venn diagram? I think this is a mistake and might lead to misleading findings.</p></disp-quote><p>While we could carry out additional RNA-seq experiments to correlate phenotypic rescue with gene expression changes in UBQLN2<sup>4XALS</sup> flies in the absence or presence of Unc-5 LOF alleles, we don’t feel the experiment would add much to the paper at this juncture. We used UBQLN2<sup>WT</sup> flies as the reference group because we had already established that wild-type UBQLN2 overexpression causes mild phenotypic abnormalities and Ub pathway deregulation in flies (Kim et al. 2018)(2). We have now performed the requested comparison to GMR in Figure1—figure supplement 2A. Consistent with UBQLN2 overexpression toxicity, all three experimental genotypes (WT, P497H, 4XALS) exhibited hundreds of gene expression differences relative to GMR-Gal4 flies.</p><disp-quote content-type="editor-comment"><p>– Figures 4 and 5 are a nice validation of the screening, but since the findings are no further investigated these figures might be better put in the supplementary.</p></disp-quote><p>We moved Figure 4 and 5 to Figure 2—figure supplement 1 and 2.</p><disp-quote content-type="editor-comment"><p>– Figure 6D: WB for Unc5 missing.</p></disp-quote><p>Unfortunately, anti-<italic>Drosophila</italic> Unc5 antibodies are not commercially available. We also attempted to generate an anti-<italic>Drosophila</italic> Unc5 mAb, but this antibody did not work. Unc-5 RT-qPCR was not sensitive enough to detect decrease in eye specific knock down from whole head total RNA.</p><disp-quote content-type="editor-comment"><p>– Figure suppl 3 should be moved in the main figure 7.</p></disp-quote><p>We moved Figure supplement 3 to Figure 4D.</p><disp-quote content-type="editor-comment"><p>– Figure 9: if these are new lines made for this paper a proper characterization should be presented (staminality markers etc). Besides this, the entire figure 9 should go in the supplementary as it functions only as a support for the data in the neurons.</p></disp-quote><p>All lines are derived from a male iPSC line that has been fully characterized for stemness and differentiation potential (Yin et al. (2019) Stem Cell Res 34, 101365.)(1). We also karyotyped the UBQLN2-P497H, 2XALS and 4XALS clone 1 and validated all findings from this clone with UBQLN2-4XALS clone 2. Because we have now complemented the iPSC/BafA1 findings with iMN data (Figure 8) we have chosen to keep the iPSC findings in the main figure panel (Figure 6 in the revised manuscript).</p><disp-quote content-type="editor-comment"><p>I also struggle to see the value of all the data with the BafA1 and of the lysosome analysis if they are no reproduced in neurons.</p></disp-quote><p>We carried out the suggested experiments in iMNs, where BafA1 strongly induced aggregation of UBQLN2<sup>4XALS</sup>, but not UBQLN2<sup>WT</sup> or UBQLN2<sup>P497H</sup>. UBQLN2<sup>4XALS</sup> aggregates were coincident with p62 aggresomes and were partially colocalized with LAMP1+ lysosomes. By contrast, UBQLN2 was only weakly colocalized with Rab5 or LC3 in BafA1-treated iMNs. This data corroborates and extends the iPSC data and is presented in Figure 8 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>– Figure suppl 8 is missing the WB for DCC to show reduced level of the protein as well as of the RNA.</p></disp-quote><p>We agree that it is preferable to corroborate the DCC knockdown result by WB. Unfortunately, we were unable to consistently detect DCC in iMN extracts using several well-characterized antibodies. We are confident that DCC levels were reduced based on RT-qPCR findings show in Figure 9—figure supplement 1.</p><p>1. Yin, Y., Petersen, A. J., Soref, C., Richards, W. D., Ludwig, T., Taapken, S., Berndt, E., Zhang, S. C., and Bhattacharyya, A. (2019) Generation of seven induced pluripotent stem cell lines from neonates of different ethnic backgrounds. Stem Cell Res 34, 101365</p><p>2. Kim, S. H., Stiles, S. G., Feichtmeier, J. M., Ramesh, N., Zhan, L., Scalf, M. A., Smith, L. M., Pandey, U. B., and Tibbetts, R. S. (2018) Mutation-dependent aggregation and toxicity in a <italic>Drosophila</italic> model for UBQLN2-associated ALS. Hum Mol Genet 27, 322-337</p><p>[Editors’ note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>1. Please include the Eye Degeneration Score in all of the figures. It can perhaps be omitted in the screening to avoid making the figure too dense, but it will be helpful in the other figures to ensure that people outside of the fly field can evaluate the differences. Including the Eye Degeneration Score will also allow evaluation of the consistency of the findings across experiments.</p></disp-quote><p>The Eye Degeneration Scores were included below the fly eye images, following the scoring criteria outlined in Figure 2B.</p><disp-quote content-type="editor-comment"><p>2. Please ensure that the Images of the fly eyes have high enough resolution to be clear (for example, Figure 3 Supplementary 1 is clear).</p></disp-quote><p>Having gone through all the figures we agree that images taken with our laboratory stereoscope do not match the clarity of images generated on Dr. Pandey’s stereoscope shown in Figure 3—figure supplement 1. However, the eye depigmentation and necrosis features used for the side-by-side phenotypic comparisons can be easily discerned regardless of the stereoscope used. That said, we have replaced certain images with better quality images that were taken from the same fly cohorts at the same time. Panel replacements include: Figure 2C (C144), Figure 2 Supplementary 2B (lilli<sup>7-2</sup>), Figure 3B (ED2426, BSC346), Figure 3C (CyO, Unc-5<sup>3</sup>, Unc-5<sup>8</sup>, shUnc-5 (TRiP)), Figure 3F (fra (#31664)), and Figure 5D (shBeat-1b, Beat-1b (p-insertion)). In Figure 2—figure supplement 2, we eliminated the fly eye images of BSC180, ED4651, and C144 as they were redundant with those shown in Figure 2C. The clarity of <italic>Drosophila</italic> eye images was also enhanced in some cases by adjusting their sharpness and brightness.</p><disp-quote content-type="editor-comment"><p>3. Please include a quantification of Figure 8C: if a decreased co-localization with these markers is claimed, Pearson's coefficient or fluorescence intensity should be added.</p></disp-quote><p>Pearson's coefficient was incorporated into Figure 8D.</p><disp-quote content-type="editor-comment"><p>4. Consider revising the choice of key words for this work to better reflect the content of the paper.</p></disp-quote><p>We substituted kye words with amyotrophic lateral sclerosis, UBQLN2, protein aggregation, induced motor neuron, genetic screen, axon guidance. Please advise if these remain inadequate.</p></body></sub-article></article>